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The development of nickel catalysis has become more prominent over the years for organic 
transformations due to its low cost and widespread availability. This thesis discusses the impact of 
nickel catalysis in organic transformations such as metallacycle–based nickel-catalyzed reductive 
couplings and reductive cross–electrophile couplings.  
Chapter 1 provides background literature to the various strategies developed by the 
Montgomery lab to control regioselectivity and enantioselectivity of stereodefined silyl–protected 
allylic alcohol products in the reductive couplings of aldehydes and alkynes. Chapter 2 discusses 
the challenges associated with synthesizing small, chiral BAC ligands along with the challenges 
faced with developing a strategy using small, chiral ligands to control regioselectivity and 
enantioselectivity in the reductive couplings of aldehydes and alkynes. During the strategy 
development process, an endo product in the ynal cyclizations was serendipitously discovered. 
However, the formation of endo product was only observed for one privileged substrate. With 
obtaining moderate regioselectivity and low enantioselectivity using small, chiral ligands, future 
work will need to investigate the synthesis of other novel BAC ligands to simultaneously obtain 
great regioselectivity and high enantioselectivity. 
Chapter 3 provides background literature to the design, synthesis and reactivity of novel, 
well–defined NHC–Ni(0) complexes to avoid the use of unstable Ni(0) precursors and in–situ 
protocols to generate the Ni(0) catalyst. Chapter 4 discusses the synthesis of novel BAC–Ni(0) 
complexes with fumarate ligands, which were the first of this class to be synthesized. Although 
 xxiii 
these novel BAC–Ni(0) complexes showed to be inactive in the reductive coupling of aldehydes 
and alkynes compared to the IMes–Ni(0) complexes, it was shown computationally that the BAC–
Ni(0) complexes prefer to undergo the ketene first pathway for catalyst activation. This pathway 
leads to a nickel hydride species that is too endergonic and not capable of forming an active 
catalyst. Future work will need to consist of determining what pi–acidic additives can allow for 
BAC–Ni(0) to be stable, yet active in the reductive coupling of aldehydes and alkynes. 
Chapter 5 provides background literature to the recent metallacycle–based reductive cross-
electrophile coupling method developed by the Montgomery to synthesize tetrasubstituted olefins. 
Chapter 6 discusses the challenges in preventing oligomerization and / or polymerization from 
occurring in the metallacycle–based reductive cross-electrophile coupling method when utilizing 
electron–deficient substrates such as alkynyl enamides, alkynyl enals, alkynyl enones and alkynyl 
enoates. Moderate yields were obtained after optimization with an alkynyl enamide. Future work 
would consist of looking at various primary alkyl halides to generate a potential substrate scope 
with alkynyl enamides. Additionally, there is the potential to synthesize bipyridine–Ni(0) 
complexes using pi–acidic additives, such as fumarates and acrylates. This would limit the 
reduction step needed to reduce the Ni(II) complex to the active Ni(0) complex and potentially 
increase the yield of product formation.  
 
 1 
Chapter 1 Introduction to Nickel–Catalyzed Reductive Couplings: Small Ligand Protocol 
Versus Large Ligand Protocol 
1.1 General Overview of Precious Versus Base Metal Catalysis 
For many years, the development of precious metal catalysis has been more prominent 
compared to the development of catalysis employing base metals for organic transformations. 
Precious metals are not as readily available and are often mined in countries with unstable political 
infrastructures, leading to concerns about cost and availability. This brings attention to the ever–
growing demand for the development of methods that utilize first–row transition metals (TMs) as 
an alternative to precious metals for catalyzing organic transformations (Figure 1-1).1 Developing 
novel base metal catalysis for organic transformations would not only be cost–effective due to the 
natural abundance of base metals compared to precious metals but would also limit the use and 
exposure of toxic metals as base metals are less toxic than precious metals. The effects of 
transitioning toward base metal catalysis have and will continue to be felt in large, industrial–scale 
processes from pharmaceuticals to agrochemicals. The content throughout this thesis will show 
the impact of nickel catalysis in organic transformations such as metallacycle base reductive 
couplings and reductive cross–electrophile couplings. 
 
Figure 1-1: a) Natural abundance of 3d, 4d and 5d transition metals (TMs)1; b) Natural abundance of 3d transition metals 
(TMs)1 
 2 
1.2 Mechanistic Outcome for Aldehyde–Alkyne Reductive Couplings 
The Montgomery lab has a long–standing focus in the development of novel nickel–
catalyzed processes.2 Specifically, the Montgomery lab was able to generate various strategies to 
control not only the regioselectivity but also the enantioselectivity of stereodefined silyl–protected 
allylic alcohol products in the reductive coupling of aldehydes and alkynes.2-8 
To understand these various strategies to control regioselectivity and enantioselectivity, the 
proposed mechanism needs to be understood (Scheme 1-1).2-8 Initially, an aldehyde and an alkyne 
in the presence of a Ni(0) catalyst will form complex 1-1. Complex 1-1 undergoes an oxidative 
cyclization to form the five-membered metallacycle 1-2. A silane enters the catalytic cycle and 
performs a s–bond metathesis with the Ni–O bond of the five-membered metallacycle 1-2 to form 
the vinylnickel(II) complex 1-3. Finally, complex 1-3 undergoes reductive elimination to afford 
the desired silyl–protected allylic alcohol product 1-4. 
 
Scheme 1-1: Proposed mechanism for aldehyde–alkyne reductive couplings 
 With an unsymmetrical alkyne, the substituents on the alkyne can differ based on sterics 
and electronics. For simplicity, RS will represent the smaller substituent on the alkyne where RL 




































aldehyde, silane and Ni catalyst will result in two regiochemical products (Scheme 1-2). Product 
1-5 acquires RS at the terminal position of the alkene. Product 1-6 acquires RL at the terminal 
position of the alkene.  
 
Scheme 1-2: Regiochemical outcome in aldehyde–alkyne reductive couplings 
1.3 Regiocontrol in Aldehyde–Alkyne Reductive Couplings 
Early work from the Montgomery lab demonstrated that the ligand structure could provide 
moderate regiocontrol in the reductive coupling of aldehydes and alkynes.3,9-11 Collaborations 
between the Jamison and Houk labs determined that phosphine ligands could only provide minimal 
regiocontrol in the reductive coupling of aldehydes and alkynes.12,13 Later work from the 
Montgomery lab exhibited good to excellent regiocontrol in the reductive coupling of aldehydes 
and alkynes after synthesizing and screening various carbene ligands.4 The two main classes of 
carbene ligands utilized for this work were N–heterocyclic carbenes (NHCs) and 
bis(amino)cyclopropenylidenes (BACs) (Figure 1-2).  
 
Figure 1-2: Skeletal framework of NHC and BAC ligands 
The NHC and BAC ligands not only provided good to excellent regiocontrol, but also 
provided regiochemical reversal depending on the size of carbene ligand (Table 1-1).4 The use of 
a large ligand was found to favor product 1-5 as the major product and the use of a small ligand 
was found to favor product 1-6 as the major product. Additionally, regiochemical reversal worked 






















alkynes (Entry 2, Table 1-1), conjugated enynes (Entry 3, Table 1-1) and strongly biased terminal 
alkynes (Entries 4 and 5, Table 1-1), making this strategy extremely useful and efficient as it 
overrides substrate biases and requires no directing functional group installation.  
 
Table 1-1: Regiochemical reversal in aldehyde–alkyne reductive couplings 
1.3.1 NHC Ligands 
Over the years, the Montgomery lab has been able to isolate and characterize diverse NHCs 
of varying steric profiles to implement and use for screening purposes in the reductive coupling of 
aldehydes and alkynes (Figure 1-3).2-8 Ligands 1-8 (SIPr•HCl) and 1-9 (IMes•HCl) are 
commercially available, while ligand 1-7 is not commercially available. When assessing the steric 
profiles of each ligand, it is best to imagine the ligand bound to a metal center, such as nickel. The 
isopropyl groups at the 2 and 6 positions of the aryl groups on ligands 1-7 and 1-8 are positioned 
to generate significant steric crowding around the metal center where the reactivity is taking place, 









































 aConditions: A: Ligand = 1-8, Base = KO-t-Bu, (i-Pr)3SiH; B: Ligand = 1-7, Base = BuLi, 
Et3SiH; C: Ligand = 1-10, Base = BuLi, (t-Bu)2SiH2; D: Ligand = 1-9, Base = KO-t-Bu, (i-
Pr)3SiH or Et3SiH
4 D, 7:93 (88)B, 85:15 (86)




























on ligand 1-9 generate less steric crowding around the metal center where the reactivity is taking 
place in comparison to ligands 1-7 and 1-8, thus creating a small steric profile. Additionally, the 
percent buried volumes (%VBur) can be calculated using Density Functional Theory (DFT) to 
compare the steric profiles of each ligand.8,14 The %VBur measures the space occupied by the ligand 
within the first coordination sphere by a percentage. Therefore, the higher the %VBur, the larger the 
ligand.8,14 For ease in understanding regiocontrol in the reductive couplings of aldehydes and 
alkynes, ligands 1-7 and 1-8 will be referred to as large ligands where ligand 1-9 will be referred 
to as a small ligand.4  
 
Figure 1-3: NHCs of varying steric profiles 
1.3.2 BAC Ligands 
Inspired by the development of using carbenes, such as NHCs, as ligands in the reductive 
coupling of aldehydes and alkynes, the Montgomery lab branched into implementing and studying 
a new class of carbenes called bis(amino)cyclopropenylidenes (BACs).4 This new class of 
carbenes was recently developed by the Bertrand lab, therefore, the diversity and evaluation of this 
ligand scaffold are lacking.15 As such, investigation in the scope of BAC ligands pose opportunities 
in broadening the synthetic utility for a variety of nickel–catalyzed processes. Ligand 1-10 (i-Pr-
BAC•HBF4), initially developed by the Bertrand lab, is the most easily synthesized and commonly 
used BAC ligand (Figure 1-4). When assessing the steric profile of 1-10, the diisopropylamino 




















36.1 %VBur 28.7 %VBura37.5 %VBur
a%VBur was calculated with a NHC-Metal distance of 2.28 Å instead of 3.5 Å
 6 
is taking place, thus creating a small steric profile. For ease in understanding regiocontrol in the 
reductive couplings of aldehydes and alkynes, ligand 1-10 will be referred to as a small ligand with 
ligand 1-9 (IMes•HCl).4 
 
Figure 1-4: i-Pr-BAC 
1.3.3 NHC Ligands Versus BAC Ligands 
There are distinct steric and electronic differences between NHCs and BACs, which has 
piqued interest into further development of these specific carbenes.15-18 Bertrand reports that these 
Hückel aromatic compounds exhibit reasonable singlet–triplet energy separation by means of 
density functional calculations.19 Using Extended Hückel (EH) calculations on 
cyclopropenylidene 1-11, Bertrand was able to describe the HOMO in a simple 
cyclopropenylidene as the s orbital, centered on the carbon with singlet-carbene character. 
Unoccupied higher energy orbitals were defined as p2 and p3 (Figure 1-5). Based off of this model, 
multiple triplet states could be described. Further calculations showed that the excitation of one 
electron from the s orbital to the p3 orbital provided the lowest-energy triplet. This is due to the 
bonding character seen in the p3 orbital whereas the p2 orbital contains only antibonding character 
and a node at the carbene carbon. The addition of amino groups to the olefinic carbons resulted in 
an approximate 20 kcal mol-1 increase of the singlet-triplet energy. An increase in the singlet-triplet 
energy separation imparted by the amino-groups for BACs is observed, however, it is still smaller 
than the singlet-triplet energy separation seen with its NHC counterparts. Although NHCs are 
calculated to have a larger singlet-triplet energy separation, the energy of the HOMO for 






cyclopropenylidenes are more nucleophilic. Taking careful consideration of sterics and electronics 
for the substituents attached to the olefinic carbons will determine the singlet-triplet energy 
separation and thus, the stability of the carbene.  
 
Figure 1-5: Energy diagram of 1-11 using EH calculations 
The engineering and design opportunities available for BAC ligands could evolve into 
unique influences for a variety of catalytic processes due to the exceptional s-donating character 
and small effective size exemplified by parameters such as percent buried volume (%Vburied). This 
stands in contrast to most NHC ligands, which exert considerable steric demand directed towards 
the metal center. 
Taking advantage of the steric and electronic differences between NHCs and BACs, the 
Montgomery lab was able to look at these ligands and classify them into two groups for the 
reductive coupling of aldehydes and alkynes.4 As previously discussed, ligands 1-7 and 1-8 were 
classified as large ligands (LL)  and ligands 1-9 and 1-10 were classified as small ligands (LS). The 
large ligands (LL) provided a different regiochemical outcome compared to the small ligands (LS), 
which led to the development of the large ligand protocol and the small ligand protocol for the 














Scheme 1-3: Regiochemical outcome in the small ligand protocol versus the large ligand protocol 
1.3.4 Large Ligand Protocol 
To understand the regiochemical outcome of favoring product 1-5 over 1-6, it is best to 
look at the first step in the catalytic cycle where the aldehyde and the alkyne are bound to Ni(0) 
catalyst (Scheme 1-5).4-7 The alkyne can be positioned in two different ways. The smaller 
substituent can lie closer in proximity to the ligand providing complex 1-12. Alternatively, the 
larger substituent can lie closer in proximity to the ligand providing complex 1-13.  When looking 
at complex 1-13, there is a large amount of steric crowding between the large ligand and the large 
substituent of the alkyne. Therefore, the formation of complex 1-12 is favored over the formation 
of complex 1-13, thus making the major product 1-5. 
 
Scheme 1-4: Comparison of complexes 1-12 and 1-13 in the large ligand protocol 
The Montgomery lab compared the regioselectivities of large ligands, 1-7 and 1-8 (Table 
1-2).4 Both ligands, 1-7 and 1-8, provided excellent regioselectivity favoring the desired product 
1-14 over 1-15. With ligand 1-8 being commercially available, this makes for a great ligand to use, 



































































Table 1-2: Regioselectivity in aldehyde–alkyne reductive couplings with ligands 1-7 and 1-8 
1.3.5 Small Ligand Protocol 
To understand the regiochemical outcome of favoring product 1-5 over 1-6, it is best to 
look at the first step in the catalytic cycle where the aldehyde and the alkyne are bound to Ni(0) 
catalyst (Scheme 1-6).4-7 The alkyne can be positioned in two different ways. The smaller 
substituent can lie closer in proximity to the ligand providing complex 1-16. Alternatively, the 
larger substituent can lie closer in proximity to the ligand providing complex 1-17.  When looking 
at complex 1-16, there is a large amount of steric crowding between the substituent on the aldehyde 
and the large substituent of the alkyne. Therefore, the formation of complex 1-17 is favored over 
the formation of complex 1-16, thus making the major product 1-6. 
 







































































The Montgomery lab compared the regioselectivities of large ligands, 1-9 and 1-10 (Table 
1-3).4 Both ligands, 1-9 and 1-10, provided moderate to excellent regioselectivity favoring the 
desired product 1-15 over 1-14. With ligand 1-9 being commercially available, this makes for a 
great ligand to use, however, ligand 1-10 was found to provide higher selectivity, particularly with 
internal bis–aliphatic substituted alkynes. 
 
Table 1-3: Regioselectivity in aldehyde–alkyne reductive couplings with ligands 1-9 and 1-10 
1.4 Complementary Regiocontrol and Enantiocontrol in Aldehyde–Alkyne Reductive 
Couplings 
With a strategy to control regioselectivity in the reductive coupling of aldehydes and 
alkynes via careful consideration of ligand size, the Montgomery lab became interested in 
developing a strategy to simultaneously control regioselectivity along with enantioselectivity.8 
When developing a strategy to control only regioselectivity, one of the two products needs to be 
favored. When developing a strategy to simultaneously control regioselectivity and 
enantioselectivity, one of the four products needs to be favored leading to a fundamental redesign 




































Scheme 1-6: Regiochemical and enantiochemical outcome in aldehyde–alkyne reductive couplings 
 To specifically favor the formation of products 1-18 and 1-19 over products 1-20 and 1-
21, the Montgomery lab focused on using the large ligand protocol.8 From there, further 
development in the synthesis of large, chiral NHCs was employed to see if high enantioselectivity 
of either product 1-18 or 1-19 could be achieved. Results from these studies showed that large, 
chiral ligand 1-22 was capable of simultaneously providing high regioselectivity and high 
enantioselectivity favoring product 1-23 (Entry 1, Table 1-4). Additionally, high regioselectivity 
and high enantioselectivity was obtained at lower catalyst loadings (Entries 2 and 3, Table 1-4), 
however, yields were compromised (Entries 2 and 3, Table 1-4). 
 
Table 1-4: Simultaneous regiocontrol and enantiocontrol in aldehyde–alkyne reductive couplings 
Further studies showed that as the small substituent of the alkyne becomes larger, for 


























Ni(COD)2 (10 mol %)
1-22 (11 mol %) 



















PhMe (0.1 M), rt, 24 h
3b 46 87>95:5
a5 mol % catalyst loading; 72 h. b2 mol % catalyst loading; 72 h. 
call enantioselectivity data was determined by supercritical fluid 
chromatography (SFC) analysis of the corresponding alcohols 












ethyl group (Entry 3, Table 1-5), the enantioselectivity increases from 13% to 28% and then to 
92%, respectively.8 The explanation behind the enantioselectivity was determined through 
computations in collaboration with the Liu lab. 
 
Table 1-5: Differences in enantioselectivity with changes in size of RS 
Specifically, the Liu lab used Density Functional Theory (DFT) calculations to study the 
oxidative cyclization transition states (Figure 1-6).8 The major enantiomeric product (S) is 
observed due to steric interactions between the phenyl substituent on the NHC backbone and from 
the ethyl substituent on the alkyne, which allows the aryl group on the NHC to lay horizontal and 
diminish the clashing between the NHC ligand and the aldehyde. The minor enantiomeric product 
(R) is also observed due to the steric interactions between the phenyl substituent on the NHC 
backbone and from the ethyl substituent on the alkyne, however, the aryl group of the NHC tilts 
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1-22 (11 mol %) 









































 aall enantioselectivity data was determined by supercritical fluid chromatography (SFC) 






Figure 1-6: Oxidative cyclization transition states using DFT calculations8 
1.5 Conclusion 
As discussed in this chapter, the Montgomery lab developed a strategy to control 
regioselectivity in reductive coupling of aldehydes and alkynes without having steric and 
electronic biases or directing groups.4 This strategy consisted of either utilizing the large ligand 
protocol or the small ligand protocol depending on the desired regioisomer product of interest. 
Additionally, the Montgomery lab developed a strategy to simultaneously control regioselectivity 
along with enantioselectivity for the large ligand protocol.8 However, future work would need to 
be completed in order to develop a strategy to simultaneously control regioselectivity along with 
enantioselectivity for the small ligand protocol (Scheme 1-8). 
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Chapter 2 Investigation of Nickel–Catalyzed Reductive Couplings: Regioselectivity and 
Enantioselectivity in Small Ligand Protocol and Ynal Cyclizations 
2.1 Small Ligand Protocol Reproducibility 
 The Montgomery lab developed a small ligand protocol in the reductive coupling of 
aldehydes and alkynes utilizing ligand 2-1 to obtain excellent regioselectivity favoring the desired 
product 2-3 over 2-2 as discussed in the previous chapter (Table 2-1).1 Reproducing these results 
was found to be very challenging as low yields and moderate regioselectivity were observed.  
 
Table 2-1: Regioselectivity in aldehyde–alkyne reductive couplings with ligand 2-1 
The low yields were believed to be due to the inconsistency in the deprotonation step of 
the i-Pr-BAC•HBF4 salt 2-1. To mitigate the reproducibility issue, the i-Pr-BAC free carbene 2-4 
was made from the i-Pr-BAC•HBF4 salt 2-1. By using the i-Pr-BAC free carbene 2-4, base was no 
































Therefore, the formation of the active nickel catalyst could proceed more efficiently. Using the i-
Pr-BAC free carbene 2-4 in combination with (i-Pr)3SiH as the reducing agent instead of t-
Bu2SiH2, higher yields and better reproducibility was observed in the reductive coupling of 
aldehydes and alkynes (Table 2-2). However, the yields were still only moderate. To improve 
yields while still obtaining high regioselectivity, engineering and design opportunities for BAC 
ligands were explored. 
 
Table 2-2: Regioselectivity in aldehyde–alkyne reductive couplings with ligand 2-4 
2.1.1 Synthesis of Small Ligands 
Initial studies began by synthesizing BAC ligands with appending heterocyclic amines, 
specifically imidazolidinones, to the cyclopropenium scaffold. By synthesizing these types of BAC 
ligands, the inherent chirality of the imidazolidinones would provide not only regioselectivity, but 
also enantioselectivity. Additionally, imidazolidinones are attractive due to their modular design 
and synthetic availability. With previous literature procedures, imidazolidinone 2-7 was 
synthesized for ease of generating preliminary studies (Scheme 2-1). The synthesis of 
imidazolidinone 2-7 was straight forward and relatively easy to separate from imidazolidinone 2-































by an acyl substitution to generate the corresponding amide product. The amide product underwent 
a Lewis acid–catalyzed cyclization with pivaldehyde to generate imidazolidinones 2-7 and 2-8. 
The Lewis acid–catalyzed cyclization step to provide imidazolidinones 2-7 and 2-8 was attempted 
via two different pathways, pathway A and pathway B. Pathway B, developed by the Tomkinson 
lab, was attempted first and no product was obtained.2 Pathway A, developed by the MacMillan 
lab, was attempted after Pathway B failed and resulted in low yields of imidazolidinones 2-7 and 
2-8.3 
 
Scheme 2-1: Synthesis of imidazolidinone 2-7 
Although imidazolidinone 2-7 was successfully separated from imidazolidinone 2-8, there 
was still unknown impurities present. To remove the impurities, imidazolidinone 2-7 was 
converted to the HCl salt and then free based (Scheme 2-2).  
 
Scheme 2-2: Purification steps for imidazolidinone 2-7 
Using a modified procedure of the i-Pr-BAC•HBF4 salt 2-1 developed from the Bertrand 
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scaffold to generate a novel BAC ligand (Scheme 2-3).4 Under those conditions, the 
characterization data confirmed that the tri-substituted product 2-9 was observed over the desired 
di-substituted product 2-10.  
 
Scheme 2-3: Attempted synthesis of BAC ligand 2-10 using Bertrand's conditions 
In an attempt to overcome tri-substitution and favor di-substitution, the amount of 
imidazolidinone 2-5 was reduced from 5 equivalents to 2.2 equivalents. To make up for the loss 
of base needed for the reaction to occur, 3 equivalents of Hünig’s base was added to the reaction 
mixture. However, no isolation of the desired di-substituted product was acquired. Additionally, a 
modified BAC procedure developed by Tamm was attempted to produce the desired di-substituted 
product 2-10 (Scheme 2-4).5 Again, only the tri-substituted product 2-9 was observed.  
 
Scheme 2-4: Attempted synthesis of BAC ligand 2-10 using Tamm's conditions 
With little success in synthesizing novel BAC ligands containing heterocyclic amines, 
specifically imidazolidinone 2-7, efforts were focused on synthesizing known chiral BAC ligands 
2-11 and 2-12 (Figure 2-1). Ligand 2-11 was developed by the Tamm lab and ligand 2-12 was 
developed by the Gravel lab.5-6 Additionally, small, chiral NHC ligands 2-13 through 2-16 were 
























































in the reductive coupling of aldehydes and alkynes to compare yield, regioselectivity and 
enantioselectivity data.  
 
Figure 2-1: Small, chiral BAC and NHC ligands 
2.2 Enantiocontrol in Small Ligand Protocol 
As previously discussed, ligands 2-11 through 2-16 were subjected to the small ligand 
protocol in the reductive coupling of aldehydes and alkynes to compare yield, regioselectivity and 
enantioselectivity data (Scheme 2-5). Ligand 2-11 provided moderate yield with good 
regioselectivity, but poor enantioselectivity. Even though ligand 2-12 was predicted to outperform 
ligand 2-11 due to its more rigid structure, the ligand unfortunately provided no product formation. 
Ligands 2-13 through 2-15 all had the chirality located on the backbone of the NHC. Ligands 2-
13 and 2-14 provided low yields with moderate regioselectivity, while ligand 2-15 provide a 
moderate yield with poor regioselectivity. Ligand 2-16, with the chirality appended off the 





























Scheme 2-5: Regioselectivity and enantioselectivity in aldehyde–alkyne reductive couplings with small, chiral ligands 
Overall, ligands 2-11 through 2-16 provided poor enantioselectivity in the reductive 
coupling of aldehydes and alkynes. Additionally, the yields and regioselectivity were 
uncomplimentary as high yields did not result in good regioselectivity. To further understand the 
complexity of simultaneously obtaining great regioselectivity and high enantioselectivity, the 
reaction components would need to be reduced in order to simplify the system.   
2.3 System Simplification with Intramolecular Cyclizations 
The reaction components were simplified to looking at ynals where the aldehyde and 
alkyne are tethered. In doing so, the regiochemical outcome is determined with a bias substrate to 
provide product 2-19 selectively (Scheme 2-6). Therefore, chiral ligands of various sizes, both 






























































all enantioselectivity data was determined by by supercritical fluid chromatography (SFC) analysis of the 
corresponding alcohols generated by TBAF deprotection.
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Scheme 2-6: Ynal cyclizations 
2.3.1 Serendipitous Endo Product Formation 
Initial studies utilized chiral ligand 2-20 in the ynal cyclizations. Surprisingly, the desired 
exo product 2-21 was not observed as the major product (Scheme 2-7). Instead, endo product 2-
22 was observed as the major product. The formation of endo product 2-22 represents an 
unprecedented reaction pathway in ynal cyclizations. Ligands 2-23 through 2-25 were also 
subjected to the reaction conditions, however, none provided the endo product 2-22 as the major 
product. To understand how the formation of endo product 2-22 was favored over the exo product 
2-21 in the presence of using ligand 2-20, mechanistic studies would need to be conducted.  
 
Scheme 2-7: Regioselectivity in ynal cyclizations with various ligands 
2.4 Mechanistic Studies for Formation of Endo Product Formation 
The formation of endo product 2-22 was hypothesized to be kinetically controlled or the 























































assessed to determine what reaction components and factors controlled the formation of endo 
product 2-22 (Table 2-3). A 95:5 mixture of exo product 2-21 to endo product 2-22 was subjected 
to the reaction conditions to evaluate a change, if any, to the ratio. When only the silane and base 
were present in the reaction mixture, there was no change to the ratio of exo to endo product (Entry 
1, Table 2-3). When only the Ni(COD)2, ligand 2-20 and base were present in the reaction mixture, 
there was also no change to the ratio of exo to endo product (Entry 2, Table 2-3). Additionally, 
when only the silane, 2-20 and base were present in the reaction mixture, there was no change to 
the ratio of exo to endo product (Entry 3, Table 2-3). A change in the ratio of exo to endo product 
was only observed when the silane and Ni(COD)2 were present in the reaction mixture (Entry 4, 
Table 2-3). Finally, when the when the mixture was subjected to the standard reaction conditions, 
there was an enrichment of endo product 2-22 (Entry 5, Table 2-3).  
 
Table 2-3: Control reaction studies in ynal cyclizations with ligand 2-20 
Additionally, the ratio of exo product 2-21 to endo product 2-22 was observed as a function 
of reaction time during the ynal cyclization to determine if the endo product 2-22 was initially 
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3 Et3SiH + 2-20 + KO-t-Bu 95:5
4 Et3SiH + Ni(COD)2 70:30

























reaction was quenched after 2 minutes, the ratio of exo product 2-21 to endo product 2-22 was 
96:4 (Entry 1; Table 2-4). When the reaction was quenched after 16 hours, the ratio of exo product 
2-21 to endo product 2-22 was 50:50 (Entry 2, Table 2-4). 
 
Table 2-4: Timed reaction studies in ynal cyclizations with ligand 2-20 
In combination of the control and timed reactions, these studies showed that the Ni(COD)2, 
2-20, base and silane were all needed to be present in the reaction mixture. Additionally, the endo 
product 2-22 gradually formed as the reaction time increased suggesting that the formation of the 
endo product 2-22 was occurring via an isomerization pathway (Scheme 2-8). After forming the 
exo product 2-21, it is proposed that a nickel-hydride species can conduct a 1,2 migratory insertion 



































Scheme 2-8: Proposed mechanism for endo product formation 2-22 
2.5 Enantiocontrol in Intramolecular Ynal Cyclizations 
With a better understanding of the mechanism for the endo product 2-27, various ynals 
were subjected to the reaction conditions with ligand 2-20 to compare yield, regioselectivity and 
enantioselectivity data (Table 2-5). Unfortunately, the ynal with RS=H and n=5 was the only 
substrate to provide formation of the endo product 2-27 (Entries 1 and 2, Table 2-5). Furthermore, 
the enantioselectivity was low. If the small substituent (RS) on the alkyne increased in sterics from 
a hydrogen to a methyl group or ethyl group, the enantioselectivity drastically decreased (Entries 
3 through 6, Table 2-5). Lastly, the ynal with RS=H and n=5 not only provided no formation of the 

































Table 2-5: Regioselectivity and enantioselectivity in ynal cyclizations with ligand 2-20 
Although it was unfortunate that the ynal with RS=H and n=5 was the only substrate to 
provide formation of the endo product 2-27, this suggests that the Ni-H species only allows for 
isomerization to occur for very specific substrate classes, diminishing the value of this new 
reactivity. Additionally, it is interesting that the formation of the more stable endo product 2-28 
was never observed under the standard reaction reactions (Figure 2-2). However, it is proposed 
that the silyl ether group is sterically encumbering to allow for the isomerization to take place 
providing the more stable endo product 2-28. 
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aall enantioselectivity data was determined by Mosher Ester Analysis of the 








2.6 Conclusion and Future Directions 
As discussed in this chapter, the synthesis of novel BAC ligands was more challenging 
than expected. Also, obtaining great regioselectivity and high enantioselectivity simultaneously in 
the small ligand protocol proved to be extremely challenging. Even though an endo product in the 
ynal cyclizations was serendipitously discovered, it was only observed for one privileged substrate. 
To further explore and understand how to simultaneously obtain great regioselectivity and high 
enantioselectivity, future work will need to investigate the synthesis of other novel BAC ligands. 
However, efforts were shifted to synthesizing discrete Ni(0) complexes in order to further improve 
reproducibility in yields, while also obtaining mechanistic data to gain further insights on how to 
improve regioselectivity and enantioselectivity in the small ligand protocol (Figure 2-3). 
 
Figure 2-3: Discrete Ni(0) complexes 
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Chapter 3 Introduction to Nickel–Catalyzed Reductive Couplings: Utility of Well–Defined 
Ni(0) Complexes 
3.1 General Overview of Ni(0) Complexes 
As discussed in the previous chapters, the development of catalysis employing base metals, 
such as nickel, for organic transformations has become a vested interest for the synthetic 
community over the past couple decades.1-4 The Montgomery lab has a long–standing focus in the 
development of novel nickel–catalyzed processes, particularly with NHC ligands.1,5-15 Generally 
speaking, the active Ni(0) catalyst is generated in situ, which can be undesirable and create many 
limitations for various processes (Scheme 3-1). First, Ni(COD)2 is used as the Ni(0) source, which 
is not air-tolerant and requires the use of a glovebox for storage. Second, the NHC used can be in 
the salt form or the free carbene form. The salt form 3-1, although stable, requires base for 
deprotonation in order to generate the active NHC–Ni(0) catalyst. The free carbene 3-2, although 
does not require base for deprotonation, is not stable and needs to be stored in the glovebox. Third, 
the quantity of NHC–Ni(0) catalyst 3-3 generated via the in situ protocols is not well defined. 
 
Scheme 3-1: NHC–Ni(0) catalyst formation 
To overcome these undesirable limitations, various types of NHC–Ni(0) complexes have 
been synthesized over the years.16-28 However, many of these NHC–Ni(0) complexes were not 















widespread use of these catalysts has been limited. In addition to these various types of NHC–
Ni(0) complexes synthesized, there were two complexes that did bring awareness to the 
Montgomery lab, which were complexes 3-4 and 3-5 (Figure 3-1).16,17 The Cavell lab developed 
the well–defined IMes–Ni(0) complex 3-4 and the Navarro lab developed the well–defined IPr–
Ni(0) complex 3-5.16,17 Both complexes showed ability to be air–tolerant, however, this came at 
the expense of reduced reactivity, specifically in the reductive coupling of aldehydes and alkynes. 
The stability of these complexes was attributed to the ancillary ligands bound to the nickel center. 
For both complexes, the ancillary ligand of choice was dimethyl fumarate (DMFU). The design of 
these particular complexes sparked interest in the Montgomery lab to use various p–acidic 
additives as ancillary ligands to generate a variety of NHC–Ni(0) complexes. Acquiring well–
defined and easy to synthesize NHC–Ni(0) complexes that maintain air–stability, but are still 
reactive was desired and had the potential to be achieved by changing the steric and electronic 
profile of p–acidic additives such as fumarate and acrylates. 
 
Figure 3-1: Ni(IMes)(dimethyl fumarate)2 3-4 and Ni(IPr)(dimethyl fumarate)2 3-5 
3.2 NHC–Ni(0) Complexes in Skipped Diene Formation 
 As discussed previously, the Montgomery lab was interested in utilizing various p–acidic 
additives as ancillary ligands to generate active, but air-tolerant NHC–Ni(0) complexes that are 
well–defined and easy to make. In a quest to develop a nickel–catalyzed net four–electron 
reductive coupling of enones / enals with alkynes to provide skipped diene product 3-6, ITol•HBF4 





























Scheme 3-2: Skipped diene formation with ligand 3-7 
Preceding studies with BAC and small NHC ligands, as discussed in chapter 2, indicated 
that it was common to observe low to moderate yields along with inconsistency in reproducing 
results.29 With ITol being considered a small NHC ligand, this created limitations in developing a 
method to generate the skipped diene products in high yields. To obtain high and consistent yields 
of the skipped diene products, well–defined complex 3-8 was synthesized. For this particular 
complex, methyl methacrylate (MMA) was utilized as the ancillary ligands. This easy to synthesize 
complex not only provided high yields increasing the reactivity from 37% to 90%, but also offered 
moderate stability upon air exposure (Scheme 3-3). Additionally, it demonstrated the utility of 
using these well–defined Ni(0) complexes.  
 

































3.3 NHC–Ni(0) Complexes in Aldehyde–Alkyne Reductive Couplings 
The well–defined IMes–Ni(0) complex 3-4 developed by the Cavell lab was subjected to 
the reaction conditions for the reductive coupling of aldehydes and alkynes (Scheme 3-4).5,16 
Unfortunately, only a trace amount of the reductive coupling product 3-9 was observed. To further 
investigate the utility of these well–defined Ni(0) complexes, the Montgomery lab synthesized a 
series of NHC–Ni(0) complexes by varying the p–acidic additives using fumarates and acrylates. 
The fumarates and acrylates varied by properties such as sterics and electronics. The Ni(0) 
complexes were then subjected to the reaction conditions for the reductive coupling of aldehydes 
and alkynes to evaluate and compare their stability and activity profiles.  
 
Scheme 3-4: Aldehyde–alkyne reductive couplings with complex 3-4 
3.3.1 Synthesis of IMes–Ni(0) Complexes 
Looking back at the well–defined IMes–Ni(0) complex 3-4 developed by the Cavell lab, it 
was thought to have performed poorly in the reductive coupling of aldehydes and alkynes due to 
the ineffective dissociation of the fumarate ligands.5,16 To improve dissociation of the fumarate 
ligands, the Montgomery lab hypothesized that the ester moiety on the fumarate would need to 
increase in size. By increasing the steric bulk of the ester moiety on the fumarate, this would create 
disfavoring steric interactions with the IMes ligand (Figure 3-2). Therefore, the binding energies 



























Figure 3-2: Steric interactions between IMes and the fumarate ligands 
Using IMes free carbene 3-2 in the presence of Ni(COD)2, various fumarates and acrylates 
were subjected to the reaction mixture to generate a series of IMes–Ni(0) complexes, 3-10 through 
3-15 (Scheme 3-5).5 Steric bulk of the ester moiety on the fumarate increased in size ranging from 
a methyl group to a tert-butyl group to generate well–defined Ni(0) complexes. Methyl acrylate 
and methyl methacrylate also generated well–defined Ni(0) complexes. In terms of the ease of 
synthesis, dimethyl fumarate is the only commercially available fumarate. The other fumarates all 
had to be synthesized.5 Methyl acrylate (MA) and methyl methacrylate (MMA) are commercially 
available; however, they need to be distilled prior to use to remove the stabilizer. It is also 
important to note that the acrylates should be used immediately following distillation to avoid 
polymerization. 
 


















































3.3.2 Analysis of IMes–Ni(0) Complexes in Aldehyde–Alkyne Reductive Couplings 
The Ni(0) complexes were subjected to the reaction conditions for the reductive coupling 
of aldehydes and alkynes to evaluate and compare their stability and activity profiles (Figure 3-
3).5 Analyzing the reaction progress data, all of the Ni(0) complexes except for complex 3-4 
provided product formation. Complexes 3-10 through 3-12 with small amounts of steric bulk on 
the ester moiety of the fumarate provided slower rates of product formation. Complex 3-13 with 
large amounts of steric bulk on the ester moiety of the fumarate provided a faster rate of product 
formation. Complex 3-13 not only provided the fastest rate of product formation, but also had the 
best overall performance. This supports the hypothesis that increasing the steric bulk of the ester 
moiety on the fumarate creates disfavoring steric interactions with the IMes ligand, thus allowing 
for dissociation to occur easier. Additionally, complex 3-15 performed better than complex 3-14.   
 
 
Figure 3-3: Reaction progress data for IMes–Ni(0) complexes in aldehyde–alkyne reductive couplings5 
Reaction progress data was also analyzed with the same complexes after they had been 
exposed to air for 24 hours (Figure 3-4).5 Complexes 3-10, 3-12 and 3-13 with fumarate ligands 
maintained their catalytic activity as seen previously when not exposed to air. However, the 














suggests that complexes with acrylate ligands are more susceptible to decomposition when 
exposed to air as compared to complexes with fumarate ligands. 
 
 
Figure 3-4: Reaction progress data for IMes–Ni(0) complexes after 24 h air exposure in aldehyde–alkyne reductive couplings5 
Of the various complexes that were synthesized and subjected to the reaction conditions 
for the reductive coupling of aldehydes and alkynes, complex 3-13 was found to provide the best 
reactivity without being compromised after being exposed to air.5  
3.4 Synthesis of Other NHC–Ni(0) Complexes 
As discussed previously, increasing the steric bulk of the ester moiety on the fumarate 
creates disfavoring steric interactions with the IMes ligand.5 When IMes is replaced with a much 
larger NHC such as IPr or SIPr, the sterics between the NHC ligand and the steric bulk of the ester 
moiety on the fumarate can be further enhanced making it difficult to form the NHC–Ni(0) 















Figure 3-5: Steric interactions between a large NHC and the fumarate ligands 
In addition to the IMes–Ni(0) complexes, other NHC–Ni(0) complexes were synthesized 
specifically with large NHCs (Scheme 3-6).5 With inherently large steric crowding from the NHCs, 
the complexes were easily synthesized and well-defined using acrylate ligands. 
 
Scheme 3-6: Synthesis of Ni(NHC)(acrylate)2 complexes 3-16 through 3-22 
3.5 Synthesis of BAC–Ni(0) Complexes 
Up until this point in time, there has been very little investigation into the synthesis of 









































































complex 3-22 (Figure 3-5).30 This particular complex of interest acquires two BAC ligands bound 
to the nickel center with the chelation of COD. It is hypothesized that two BAC ligands can be 
bound to the nickel center simultaneously due to its small steric profile.  
 
Figure 3-6: Ni(BAC)2(COD) 3-23 
With BAC–Ni(0) scaffolds lacking, the Montgomery lab became interested in synthesizing 
these novel complexes as it poses opportunities to broaden the synthetic utility for a variety of 
nickel–catalyzed processes. Since the BAC ligands proved to be successful ligand in the reductive 
coupling of aldehydes and alkynes, the BAC–Ni(0) scaffolds could be evaluated for reactivity, 
reproducibility and stability. Furthermore, the Montgomery lab was also interested to see if the 
mono BAC–Ni(0) complex 3-25 could be favored over the bis BAC–Ni(0) complex 3-24 (Scheme 
3-7). 
 
Scheme 3-7: Favoring mono BAC–Ni(0) complex 3-25 over bis BAC–Ni(0) complex 3-24 
3.6 Conclusion 
As discussed in this chapter, the Montgomery lab was successful at synthesizing various 
NHC–Ni(0) complexes that provided a range of reactivity and stability profiles in various nickel-
catalyzed processes.5,21,22,29 However, it was still unclear how the dissociation of the ancillary 



















aldehydes and alkynes (Scheme 3-8). Was it just a simple ligand dissociation in exchange for the 
reactive substrates or was it something more complex?  
 
Scheme 3-8: Ni(0) catalyst activation 
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Chapter 4 Investigation of Nickel–Catalyzed Reductive Couplings: Catalyst Activation of 
Ni(0) Complexes 
4.1 Synthesis of IMes–Ni(0) Complexes Extension 
The Montgomery lab synthesized various novel NHC–Ni(0) complexes that provided a 
range of reactivity and stability profiles as discussed in the previous chapter.1-4 Specifically 
focusing on the IMes–Ni(0) complexes with fumarate ligands, this particular class of complexes 
was expanded including additional fumarates of varying steric and electronic properties (Scheme 
4-1).1 This sizable class of IMes–Ni(0) complexes with fumarate ligands allowed for a large pool 
of data to be obtained in order to better compare their activity and stability profiles in the reductive 
coupling of aldehydes and alkynes.  
 40 
 
Scheme 4-1: Expansion on the synthesis of IMes–Ni(0) complexes 
4.2 IMes–Ni(0) Complexes in Aldehyde–Alkyne Reductive Couplings Extension 
The IMes–Ni(0) complexes were subjected to the reaction conditions for the reductive 
coupling of aldehydes and alkynes to evaluate and compare their stability and activity profiles. 
The IMes–Ni(0) complexes with alkyl fumarates provided high yields of product 4-13 with the 
exception of complex 4-2 (Figure 3-3). As seen in previous studies, it was expected to see little to 







































































Scheme 4-2: Aldehyde–alkyne reductive couplings with IMes–Ni(0) complexes 4-2, 4-4 and 4-6 
The IMes–Ni(0) complexes with aryl fumarates all provided product formation of 4-13. 
However, the yields varied between the different IMes–Ni(0) complexes. Complexes 4-10, 4-7 
and 4-8 gave the lowest yields of 17%, 20% and 27%, respectively, for product 4-13. Complex 4-
9 gave a modest yield of 55% for product 4-13. Lastly, complexes 4-11 and 4-12 gave high yields 
of 76% and 80%, respectively, for product 4-13. Between the data shown here and the data 
discussed in the previous chapter, complex 4-6 of the IMes–Ni(0) complexes with alkyl fumarates 
and complex 4-12 of the IMes–Ni(0) complexes with aryl fumarates provided the best reactivity 
































Scheme 4-3: Aldehyde–alkyne reductive couplings with IMes–Ni(0) complexes 4-7 through 4-12 
Additionally, reaction progress data was analyzed for some selected IMes–Ni(0) 
complexes with aryl fumarates and compared to reaction progress data for IMes–Ni(0) complexes 
with alkyl fumarates discussed in the previous chapter (Figure 4-1).1 As previously discussed, 
complex 4-6 was found to provide the best reactivity of the IMes–Ni(0) complexes with alkyl 
fumarates. Using complex 4-6 as a reference, complex 4-12 provided great reactivity. However, 
complex 4-7 provided no reactivity. This is thought to be due to the electron–withdrawing groups 
on the aryl groups of the fumarates. These electron–withdrawing groups on the fumarate allow for 
significant p back–bonding of the Ni to the fumarate. Therefore, the dissociation of the fumarate 





























































Figure 4-1: Reaction progress data for IMes–Ni(0) complexes in aldehyde–alkyne reductive couplings extension5 
4.3 Synthesis of BAC–Ni(0) Complexes Extension 
Since the only known nickel complex with a BAC ligand synthesized is complex 4-15, the 
Montgomery lab was interested in synthesizing novel BAC–Ni(0) complexes (Figure 4-2).6 This 
posed new opportunities in broadening the synthetic utility for a variety of nickel–catalyzed 
processes such as the reductive coupling of aldehydes and alkynes. The successful design and 
synthesis of NHC–Ni(0) complexes using p–acidic additives, such as fumarates and acrylates, 
became the inspiration to synthesizing BAC–Ni(0) complex 4-16 (Scheme 4-5).  
 
Figure 4-2: BAC–Ni(0) complexes 4-15 and 4-16 
Using i-Pr-BAC free carbene 4-17 in the presence of Ni(COD)2, various fumarates and 
acrylates were subjected to the reaction mixture to generate a series of BAC–Ni(0) complexes, 4-
18 through 4-20 (Scheme 4-4). Of the various fumarates and acrylates subjected to the reaction 

























The synthesis of these were complexes were relatively straight forward. The solvent of choice for 
the reaction was THF and the i-Pr-BAC free carbene 4-17: Ni(COD)2:fumarate ratio was 1:1:2, 
respectfully. During the purification of complexes 4-18 and 4-20, a brown-black sludge would 
precipitate out. It was assumed that this black-brown sludge consisted of metal decomposition 
products. Once the sludge was filtered away via a cotton plug, the complexes could then be 
crystallized using Et2O and pentane. Complex 4-19 was crystallized using THF and pentane. All 
three complexes provided an orange crystalline powder. Although complex 4-18 was obtained in 
low yields, complexes 4-19 and 4-20 were obtained in moderately high yields.  
 
Scheme 4-4: Synthesis of Ni(BAC)(fumarate)2 complexes 4-18 through 4-20 
4.4 BAC–Ni(0) Complexes in Aldehyde–Alkyne Reductive Couplings 
The BAC–Ni(0) complexes, specifically 4-18 and 4-19, were subjected to the reaction 
conditions for the reductive coupling of aldehydes and alkynes to evaluate and compare their 
stability and activity profiles (Table 4-1). Unfortunately, neither complex allowed for product 
formation to occur. This was very surprising because previous studies discussed in previous 
chapters have shown that i-Pr-BAC was capable of being a great ligand in these types of reductive 
coupling reactions. Additionally, previous studies discussed earlier in this chapter have shown that 
Ni(0) complexes with fumarates were capable of undergoing dissociation to allow for active 
Ni(COD)2 (1.0 eq)


























catalyst formation. This data suggested that the active catalyst may not form through a simple 
ligand dissociation.   
 
Table 4-1: Aldehyde–alkyne reductive couplings with BAC–Ni(0) complexes 4-18 and 4-19 
4.5 Catalyst Activation Pathways Via Computational Investigations 
Thus far, this chapter has shown that most of the NHC–Ni(0) complexes were capable of 
forming product 4-23 in the reductive coupling of aldehydes and alkynes (Scheme 4-5). However, 
the BAC–Ni(0) complexes were uncapable of forming product 4-23 in the reductive coupling of 
aldehydes and alkynes (Scheme 4-5). To gain more insight into why the NHC–Ni(0) complexes 
were more active than the BAC–Ni(0) complexes, the pathways to catalyst activation were studied 
computationally. 
 
Scheme 4-5: Ni(0) complexes in aldehyde–alkyne reductive couplings 
Previous computational studies for the three–component cycloaddition of aldehydes, 
alkynes and enoates proposed two potential pathways to product formation (Scheme 4-6).7 
Between the aldol first pathway and the ketene first pathway, the relative rates generally favored 
the ketene first pathway. However, the aldol first pathway was favored in the presence of a-
















































Scheme 4-6: Potential pathways for three–component cycloaddition of aldehydes, alkynes and enoates 
These computational studies provided insight to the potential pathways for the Ni(0) 
catalyst activation in the reductive coupling of aldehydes and alkynes.7 With the ability to map 
intermediate structures for the Ni(0) catalyst activation based off of the previous computational 
data from the three–component cycloaddition, it was also proposed that the Ni(0) catalyst 
activation could undergo a ketene first pathway or an aldol first pathway (Scheme 4-7). Initial 
computational studies began by investigating IMes–Ni(0) complex 4-12 and BAC–Ni(0) complex 
4-19. 
 









































































































For both complexes 4-12 and 4-19, the potential energy surfaces were mapped out for the 
aldol first pathway and the ketene first pathway (Figure 4-3). IMes–Ni(0) complex 4-12 is 
represented in blue and BAC–Ni(0) complex 4-19 is represented in red. When comparing the aldol 
first pathway (dark blue) to the ketene first pathway (light blue) for IMes–Ni(0) complex 4-12, the 
ketene elimination of IMes-II to IMes-III-B is slower (IMes-TS-II-B, 22.0 kcal/mol) than the 
isomerization of IMes-II to IMes-III-A (IMes-TS-II-A, 15.1 kcal/mol). Therefore, IMes–Ni(0) 
complex 4-12 is proposed to go through the aldol first pathway. When comparing the aldol first 
pathway (dark red) to the ketene first pathway (light red) for BAC–Ni(0) complex 4-19, the ketene 
elimination of BAC-II to BAC-III-B is faster (BAC-TS-II-B, 13.4 kcal.mol) than the isomerization 
of BAC-III-A to BAC-IV-A (BAC-TS-III-A, 19.5 kcal/mol). Therefore, BAC–Ni(0) complex 4-
19 is proposed to go through the ketene first pathway. 
 
Figure 4-3: Potential energy surfaces for Ni(0) catalyst activation pathways of complexes 4-12 and 4-198 
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 Since IMes–Ni(0) complex 4-12 is proposed to go through the aldol first pathway and 
BAC–Ni(0) complex 4-19 is proposed to go through the ketene first pathway, additional 
computational studies were conducted for each Ni(0) complex pathway to see why IMes–Ni(0) 
complex 4-12 is active and BAC–Ni(0) complex 4-19 is inactive. For IMes–Ni(0) complex 4-12, 
the mechanism allows for active catalyst formation (Figure 4-4 and Figure 4-5). 
 
Figure 4-4: Potential energy surfaces for complex 4-12 in the aldol first pathway part 18 
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Figure 4-5: Potential energy surfaces for complex 4-12 in the aldol first pathway part 28 
 Experimentally, a reaction was conducted to see if any intermediates could be isolated. 
From the reaction mixture, a small amount of 4-23 was cleanly isolated and 4-24 was detected by 
GCMS (Scheme 4-8). The ability to isolate and detect products 4-23 and 4-24 confirmed that the 
computations were accurate with IMes–Ni(0) complex 4-12 proceeding through an aldol first 
pathway through fumarate decomposition. 
 
Scheme 4-8: Fumarate decomposition provides products 4-23 and 4-24 
 As for BAC–Ni(0) complex 4-19, the mechanism allows for nickel hydride species BAC-
V-B to form (Figure 4-6). Unfortunately, the reductive elimination of this nickel hydride species 


















pathway for BAC–Ni(0) complex 4-19 does not yield product formation in the reductive coupling 
of aldehydes and alkynes. 
 
Figure 4-6: Potential energy surfaces for complex 4-19 in the ketene first pathway8 
 4.6 Conclusion and Future Directions 
As discussed in this chapter, many various Ni(0) complexes were synthesized. The NHC–
Ni(0) complexes with fumarate ligands that provided reactivity were found to go through the aldol 
first pathway to lead to Ni(0) catalyst activation. Additionally, the synthesis of novel BAC–Ni(0) 
complexes with fumarate ligands were the first of this class to be synthesized. Although these 
novel BAC–Ni(0) complexes showed to be inactive in the reductive coupling of aldehydes and 
alkynes compared to the IMes–Ni(0) complexes, it was shown computationally that the BAC–
Ni(0) complexes prefer to undergo the ketene first pathway for catalyst activation. However, this 
pathway leads to a nickel hydride species that is too endergonic and not capable of forming an 
active catalyst. Future work will need to consist of synthesizing various BAC–Ni(0) complexes 
with other p–acidic additives. Additional computations could potentially help determine what kind 
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of p–acidic additives can allow for BAC–Ni(0) complexes to be stable, yet active in the reductive 
coupling of aldehydes and alkynes. 
Furthermore, it would be advantageous to expand the synthesis of Ni(0) complexes to 
include chiral ligands. A few chiral NHC-Ni(0) complexes have been synthesized (Scheme 4-9). 
Initial results with these complexes showed trace reactivity in the reductive coupling of aldehydes 
and alkynes, however, more exploratory work with these complexes need to be done. 
 
Scheme 4-9: Synthesis of chiral Ni(NHC)(fumarate)2 complexes 4-25 through 4-27 
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Chapter 5 Introduction to Nickel–Catalyzed Reductive Cross–Electrophile Couplings 
5.1 Cyclization of Ynals, Alkynyl Enones and Alkynyl Enals 
In addition to developing a reductive coupling of aldehydes and alkynes, the Montgomery 
lab also extended this reactivity to intramolecular reductive coupling of ynals.1-9 As discussed in 
chapter 2, the combination of an ynal and a silane reductant afforded silyl–protected allylic alcohol 
products 5-2 and 5-4 (Scheme 5-1). Additionally, the Montgomery lab has used other reductants 
in reductive couplings to generate allylic alcohol products 5-1 and 5-3 (Scheme 5-1). These 
alternative reductants consisted of alkyl metal reagents such as dialkylzinc and trialkylaluminum. 
Using these types of reductants, an alkyl group can be appended selectively to the distal position 
of the alkyne. This reactivity was applied to both internal and terminal ynal substrates affording 
tetrasubstituted and trisubstituted olefins, respectively. The Jamison lab developed a 
complementary method in the reductive couplings using trialkylboranes.10,11 Like the other 
methods that used an alkyl metal reagent in the reductive couplings, an alkyl group was appended 
to the distal position of the alkyne. 
 































The mechanism of the these ynal cyclizations is very similar to the reductive coupling of 
aldehydes and alkynes as discussed previously in chapters 1 and 2 (Scheme 5-2).1-11 The ynal in 
the presence of a Ni(0) catalyst will form complex 5-5. Complex 5-5 undergoes an oxidative 
cyclization to form the five-membered metallacycle 5-6. The alkyl metal reductant enters the 
catalytic cycle and performs a s–bond metathesis with the Ni–O bond of the five-membered 
metallacycle 5-6 to form the vinylnickel(II) complex 5-7. Finally, complex 5-7 undergoes 
reductive elimination to afford the desired allylic alcohol product 5-8. 
 
Scheme 5-2: Proposed mechanism for ynal cyclizations 
Despite the success of these methodologies, using alkyl metal reagents presents significant 
limitations to generate tetrasubstituted and trisubstituted olefins.12 These alkyl metal reagents are 
highly reactive and generally need to be synthesized prior to use, therefore limiting its scope and 
functional group tolerance. New methodology would need to be studied to improve the synthesis 
of tetrasubstituted and trisubstituted olefins making it more applicable for general purposes. To 
achieve this, the Montgomery lab proposed the idea of intercepting the Ni(II) metallacycle 
































tetrasubstituted and trisubstituted olefins by making it more applicable for general purposes and 
would not require the need to pre-generate stoichiometric amounts of alkyl metal reagents. 
 
Scheme 5-3: Merging of Ni–catalyzed methodologies 
5.2 Cross–Electrophile Couplings 
Cross–electrophile couplings have become an extensively studied reaction class to 
construct C–C bonds.13 This type of reductive coupling involves the joining of two electrophilic 
substrates without the use of pre–generated stoichiometric amounts of reactive organometallic 
coupling partners. Generally speaking, two electrophilic coupling partners in the presence of a 
catalyst, commonly Ni, and a stoichiometric reductant allow for the formation of C–C bonds.13-22 
For example, an aryl halide and an alkyl halide can provide alkyl substituted aryl species 5-11 
(Scheme 5-4).  
 
Scheme 5-4: Cross–electrophile couplings 
During the formation of these alkyl substituted aryl species, a carbon–centered radical is 
formed from the alkyl halide species.13-22 This radical species can then add to the Ni(II) 
intermediate 5-10 from the aryl halide to form the desired product 5-11. Generally speaking, it has 
been found that ligands used in nickel–catalyzed cross–electrophile couplings need to be able to 
accept electrons to stabilize anionic nickel complexes formed during the reaction.14 Therefore, 




























(BOX) and pyridine–bis(oxazoline) (PyBOX) ligands to allow for valence tautomerism (Figure 5-
1).13-22 
 
Figure 5-1: Various N–donor ligands 
As discussed previously, if the Ni(II) intermediate 5-10 was replaced with the Ni(II) 
intermediate 5-6 from the ynal cyclization, an alkyl radical species could add in forming 
tetrasubstituted and trisubstituted olefin products 5-12 (Scheme 5-5).12 If successful, this would 
allow for rapid generation of tetrasubstituted alkynes without the need to to pre–generate 
stoichiometric amounts of reactive organometallic coupling partners.  
 
Scheme 5-5: Merging of ynal oxidative cyclization and cross–electrophile couplings 
5.3 Merging of Ynal Oxidative Cyclization and Cross–Electrophile Couplings 
Studies from the Montgomery lab of these ynal oxidative cyclizations merged with cross–
electrophile couplings were successful (Scheme 5-6).12 Triethylchlorosilane (TESCl) was added 
as additive to produce the Ni(II) halide species needed for the alkyl radical species to add in 
generating the desired tetrasubstituted product. Of the various bipyridyl ligands screened, 2,2’-
bipyridine was found to be the optimal ligand. To avoid generating the active catalyst in situ, (2,2’-
bipyridyl)nickel(II) iodide ((bipy)NiI2) was synthesized as an air–tolerant catalyst. Between Mn0 
and Zn0, Mn0 proved to be a better reductant. For the reaction solvent, N, N–dimethylformamide 
(DMF) was found to result in higher product yields over N, N–dimethylpropyleneurea (DMPU). 



































Finkelstein reaction to occur with the alkyl bromides to slow down and prevent dimerization of 
the alkyl radicals.23 Esters, acetals, amides, thiophenes, and uracils were tolerated in the nickel–
catalyzed reductive cross–electrophile couplings providing moderate to high yields (5-13 through 
5-18). 
 
Scheme 5-6: Ni–catalyzed reductive cross–electrophile coupling scope 
Furthermore, the desired product was formed as a mixture of E and Z isomers.12 This 
mixture of isomers was thought to be the result of isomerization of the vinylnickel intermediate 
based on previous literature studies.20,24- The concentration of the reaction mixture was found to 
drastically impact the olefin geometry (Table 5-1).12 As the concentration of the reaction mixture 
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Table 5-1: Concentration impact on E to Z selectivity 
This observation was proposed to be the result of a decreased rate of isomerization of the 
E vinylnickel intermediate to the Z vinylnickel intermediate at higher concentrations relative to the 
addition of the alkyl halide, favoring the E isomer over the Z isomer (Scheme 5-7).12 
 
Scheme 5-7: Mechanism for E to Z isomerization 
5.4 Proposed Mechanism of Alkylative Cyclizations 
In order to better understand the developed reaction, mechanistic studies were undertaken. 
The general mechanism begins with the reduction of the Ni(II) catalyst to Ni(0) by Mn0 (Scheme 
5-8).12 Coordination of the ynal can then coordinate to the Ni(0) species allows for oxidative 
cyclization to yield the five–membered metallacycle 5-24. The five–membered metallacycle 5-24 
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form the vinylnickel(II) complex 5-25. From the vinylnickel(II) complex 5-25, there are two 
potential pathways to product formation. Initially, it was proposed that an alkyl radical could add 
to the vinylnickel(II) complex 5-25 to form the Ni(III) complex 5-27 shown as path A. Instead, it 
was also proposed that Mn0 could reduce the vinylnickel(II) complex 5-25 to the vinylnickel(I) 
complex 5-26. Addition of the alkyl halide via a single electron transfer (SET) to the vinylnickel(I) 
complex 5-26 forms the Ni(III) complex 5-27 shown as path B. Both pathways lead to the 
formation of the Ni(III) complex 5-27. From there, reductive elimination can occur to provide 
product formation 5-28. The Ni(I) complex in then reduced by Mn0 to Ni(0) in order to reenter that 
catalytic cycle.  
 
Scheme 5-8: Proposed mechanism for Ni–catalyzed reductive cross–electrophile couplings 
Mechanistic studies were conducted where a stoichiometric amount of the Ni(0) catalyst was used 
in the reaction mixture to omit the use of a reductant.12 From these studies, there was no product 


















































As discussed in this chapter, the Montgomery lab was able to develop a method to 
synthesize tetrasubstituted olefins via an oxidative cyclization / reductive cross–electrophile 
coupling.12 This provided moderate to high yields along with excellent E to Z selectivity. Future 
work would need to be explored to expand the substrate capability of this new methodology 
(Scheme 5-9). 
 
Scheme 5-9: Future substrate exploration for Ni–catalyzed reductive cross–electrophile couplings 
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Chapter 6 Investigation of Nickel–Catalyzed Reductive Cross–Electrophile Couplings 
6.1 Optimization Screens with Alkynyl Enals 
Given the success of the previous chemistry, the Montgomery lab became interested in 
extending this methodology to other aldehyde / alkyne coupling partners demonstrated in the 
traditional Ni–catalyzed reductive couplings. Initial studies began with a–b unsaturated aldehydes 
tethered to an alkyne called alkynyl enals.1 Previous studies in the Montgomery lab have shown 
that alkynyl enals are capable of undergoing a nickel–catalyzed reductive couplings using 
dialkylzinc as the reductant to provide tetrasubstituted and trisubstituted olefin products 6-2 
(Scheme 6-1).2-10 It is important to note that the oxidative cyclization of these alkynyl enals forms 
a seven–membered metallacycle instead of a five–membered metallacycle.  
 
Scheme 6-1: Reductive couplings with alkynyl enals 
Using similar methodology as discussed in the previous chapter, an alkyl radical species 
could add into the Ni(II) complex 6-1 forming tetrasubstituted and trisubstituted olefin products 
6-3 (Scheme 6-2).1 Not only would this class of substrates expand nickel–catalyzed reductive 














Scheme 6-2: Ni–catalyzed reductive cross–electrophile couplings with alkynyl enals  
Initial studies with an alkynyl enal provided only trace amount of product 6-4 (Scheme 6-
3). To confirm product 6-4 formation, characterization data was obtained (Figure 6-1). In addition 
to 1H NMR and 13C NMR, 2D COSY NMR confirmed product formation. Proton Ha was irradiated 
using 1D NOESY NMR and confirmed that Ha and the n-butyl group were cis to each other. The 
protons on the alkene were evaluated by coupling constants. Previous studies from the formation 
of enone–alkyne reductive couplings in the Montgomery lab provided a coupling constant of J = 
6 for the protons on the alkene when they were cis.11 Since the coupling constant obtained from 
the formation alkynyl enal Ni–catalyzed reductive cross–electrophile coupling is much larger, it is 
believed that the protons on the alkene are trans to each other. 
 
Scheme 6-3: Alkylative cyclization to provide product 6-4 
 
Figure 6-1: NMR studies for product 6-4 identification 
Optimization screens were conducted by looking at various ligand scaffolds, reductants, 
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was thought that the silyl enol ether in the product was unstable leading to decomposition of the 
desired product 6-4. 
 
Table 6-1: Optimization screening with an alkynyl enal 
 To prevent this from occurring, the silyl enol ether was deprotected by adding a solution 
of tetrabutylammonium fluoride (TBAF) to the reaction mixture prior to quenching (Scheme 6-4). 
Once again, only trace amount of product 6-10 was observed with the addition of the TBAF 
deprotection. Repeating the optimization screens done previously, there was still no improvement 
to the formation of desired product. However, it is important to note that all of the crude reaction 
1H NMRs showed very broad peaks throughout the spectral data. This suggests that 
oligomerization and / or polymerization may be occurring. The oligomerization and / or 
polymerization could be potentially happening after the TBAF deprotection of the silyl enol ether. 
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* yield includes the presence of an unknown isomer of the product











undergo further manipulation with unreactive starting material to generate oligomers and / or 
polymers. Studies with alkynyl enals were halted and further optimization was conducted with 
alkynyl enamides. 
 
Scheme 6-4: Alkylative cyclization followed by a TBAF deprotection to provide product 6-10 
6.2 Optimization Screens with Alkynyl Enamides 
Initial studies with an alkynyl enamide provided a low yield of 22% with moderate E to Z 
selectivity (Scheme 6-5). Despite the low reactivity, this was a large improvement compared to 
the studies conducted with the alkynyl enal. In addition to the desired formation of product 6-11, 
there was an additional formation of product 6-12 in much lower yields, presumably via reduction 
of the corresponding vinylnickel complex.  
 
Scheme 6-5: Alkylative cyclization followed by a TBAF deprotection to provide the desired product 6-11 
Since previous studies discussed in chapter 5 showed that concentration played a key role 
in the E to Z selectivity, the concentration of the reaction mixture was screened (Table 6-2).1 
Results from the concentration screen showed relatively no change in the E to Z selectivity. 
However, the concentration of the reaction mixture played a large role in the yield of the desired 
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the yield of the desired product 6-11 increased from 17% to 50%. The yield of the undesired 
product 6-12 remained low. 
 
Table 6-2: Concentration screening 
Further studies were conducted using a 0.1 M concentration of the reaction mixture. 
Looking at other various ligands, they all proved to be less efficient than the 2,2’–bipyridine in 
terms of the desired formation of product 6-11 (Table 6-3). However, ligands all showed 





1. Et3SiCl (1.5 eq)
(bipy)NiI2 (10 mol %)
Mn0 (2.0 eq)
NaI (50 mol %)
DMF (1.0 M), rt










Entry Deviation 6-11 (% Yield) 6-11 (E:Z)6-12 (% Yield)
2 DMF (0.5 M) 17 5
3 DMF (0.2 M) 345
64:36
71:29
4 DMF (0.1 M) 650 73:27





1 no deviation 22 5 66:34
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Table 6-3: Ligand screening 
Lastly, a few other screening studies were conducted (Table 6-4). Changing the 
chlorosilane from TESCl to triisopropylsilyl chloride (TIPSCl) (Entry 2, Table 6-4) or tert-
butyl(chloro)diphenylsilane (TBDPSCl) (Entry 3, Table 6-4) did not result in an improvement in 
yield of product 6-11. However, TESCl showed improvement in E to Z selectivity favoring the E 
product over the Z product. Lastly, a secondary alkyl bromide was used instead of a primary alkyl 
halide and there was no improvement in the yield of product 6-11 (Entry 3, Table 6-4). With many 
screening studies exhausted, other electron–deficient alkene substrates were looked at using a 0.1 
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Table 6-4: Additional screening 
6.3 Substrate Scope with Electron–Deficient Alkenes 
Analyzing all of the various electron–deficient alkene substrates subjected to the reaction 
mixture, the alkynyl enamide 6-13 provided the highest yield in product formation (Scheme 6-6). 
As discussed previously, the alkynyl enal 6-14 provided a trace amount of product. The substrate 
with the a–b unsaturated ketone 6-15 only provided decomposition of starting material along with 
big broad peaks in the crude 1H NMR suggesting that oligomerization and / or polymerization is 
occurring with this particular substrate as well. The substrate with the a–b unsaturated ester 6-16 
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2 TIPSCl instead of TESCl 1633 90:10
3 TBDPSCl instead of TESCl 30 10















Scheme 6-6: Substrate scope with electron–deficient alkenes 
6.4 Conclusion and Future Directions 
As discussed in this chapter, the concentration of the reaction mixture played a large role 
in improving the yield of the desired product from the alkynyl enamide. However, the 
concentration of the reaction mixture did not seem to change the E to Z selectivity as hypothesized. 
With a 50% yield of the desired product and moderate E to Z selectivity from the alkynyl enamide, 
future work would consist of looking at various primary alkyl halides to generate a potential 
substrate scope.  
As for the other electron–deficient substrates, future work would need to consist of 
preventing oligomerization and / or polymerization from occurring. If the pathway to 
oligomerization and / or polymerization can be prevented, higher yields of the desired product are 
thought to be obtained. Other electron–deficient substrates and alkyl halides would also need to be 
screened as well.  
Lastly, there is the potential to synthesize bipyridine–Ni(0) complexes using p–acidic 
additives, such as fumarates and acrylates (Figure 6-2). This would limit the reduction step needed 
to reduce the Ni(II) complex to the active Ni(0) complex and potentially increase the yield of 
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Figure 6-2: Bipyridine–Ni(0) complexes 
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Chapter 7 Conclusion and Future Directions 
 
 
As discussed in chapter 2, obtaining great regioselectivity and high enantioselectivity 
simultaneously in the small ligand protocol proved to be extremely challenging. An endo product 
in the ynal cyclizations was serendipitously discovered during the strategy development process, 
however, it was only observed for one privileged substrate. Additionally, only moderate 
regioselectivity and low enantioselectivity using small, chiral ligands was obtained. Therefore, 
future work will need to investigate the synthesis of other novel BAC ligands to simultaneously 
obtain great regioselectivity and high enantioselectivity. Obtaining mechanistic data by analyzing 
discrete Ni(0) complexes could gain further insights on how to improve regioselectivity and 
enantioselectivity in the small ligand protocol. 
As discussed in chapter 4, many various novel Ni(0) complexes were synthesized. The 
NHC–Ni(0) complexes with fumarate ligands that provided reactivity were found to go through 
the aldol first pathway to lead to Ni(0) catalyst activation. The BAC–Ni(0) complexes with 
fumarate ligands were unreactive and were found to go through the ketene first pathway to lead to 
Ni(0) catalyst activation. Future work will need to consist of synthesizing various BAC–Ni(0) 
complexes with other p–acidic additives. Additional computations could potentially help 
determine what kind of p–acidic additives can allow for BAC–Ni(0) complexes to be stable, yet 
active in the reductive coupling of aldehydes and alkynes. Furthermore, it would be advantageous 
to expand the synthesis of Ni(0) complexes to include chiral ligands. 
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As discussed in chapter 6, moderate yields were obtained after optimization with an alkynyl 
enamide. Future work would consist of looking at various primary alkyl halides to generate a 
potential substrate scope with alkynyl enamides. As for the other electron–deficient substrates, 
future work would need to consist of preventing oligomerization and / or polymerization from 
occurring. If the pathway to oligomerization and / or polymerization can be prevented, higher 
yields of the desired product are thought to be obtained. Additionally, there is the potential to 
synthesize bipyridine–Ni(0) complexes using p–acidic additives, such as fumarates and acrylates. 
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Chapter 8 Supporting Information 
8.1 General Experimental Details 
All reactions were conducted in flame-dried or oven-dried (120 ºC) glassware with 
magnetic stirring under a nitrogen atmosphere in a glovebox or using standard Schlenk techniques, 
unless otherwise specified. All solvents (except Pentane) were purchased from Fisher Scientific 
and purified under nitrogen using a solvent purification system (Innovative Technology, Inc. 
Model # SPS-400-3 and PS-400-3). Solvents used for the synthesis of Ni(0) complexes were 
additionally freeze pump thawed prior to use. Pentane was purchased anhydrous from Millipore 
Sigma for the synthesis of Ni(0) complexes and freeze pump thawed prior to use. All deuterated 
solvents were purchased from Cambridge Isotope Laboratories, Inc. Deuterated benzene-d6 and 
tetrahydrofuran-d8 were freeze pump thawed prior to use. Ni(COD)2 was purchased from Strem 
Chemicals, Inc. and stored in the glovebox freezer (-20 ºC). (1,3-dimesitylimidazolin-2-
ylidene)bis(dimethyl fumarate)-nickel(0) was prepared according to a previous literature 
procedure.1 All amines, aldehydes, alkynes and silanes that were liquids at room temperature were 
distilled prior to use. 
Analytical thin layer chromatography (TLC) was performed on Kieselgel 60 F254 (250 µm 
silica gel) glass plates where compounds were visualized using UV light, potassium permanganate 
or ceric ammonium molybdate stains. Compounds were purified via flash column chromatography 
using Kieselgel 60 (230-400 mesh) silica gel. Automated flash column chromatography was 
performed on a Biotage IsoleraTM.   
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1 H–Nuclear Magnetic Resonance (1H NMR) and 13 C–Nuclear Magnetic Resonance (13C 
NMR) were recorded on Varian MR400 MHz, Varian Inova 500 MHz, Varian Vnmrs 500 MHz, 
and Varian Vnmrs 700 MHz. NMR spectra were recorded in a deuterated solvent from an internal 
standard of residual solvent at room temperature unless otherwise stated. High–resolution mass 
spectra (HRMS) were recorded on a VG–70–250–s spectrometer manufactured by Micromass 
Corp. (Manchester UK) at the University of Michigan Mass Spectrometry Laboratory.  





2-9 was prepared in combination of previous literature procedures with slight modifications.3,4,5 
An oven-dried (120 ºC) round-bottom flask equipped with a stir bar was charged with DCM (1.2 
mL, 0.15 M) and tetrachlorocyclopropene (0.042 mL, 1 equiv, 0.3409 mmol). The solution was 
cooled to 0 ºC and imidazolidinone 2-7 (0.4199 g, 5 equiv, 1.7045 mmol) in a solution of DCM 
(1.0 mL, 0.15 M) was added dropwise. The solution was warmed to room temperature and stirred 
for 6 hours. NaBF4 (0.0374 g, 1 equiv, 0.3409 mmol) was added and the solution stirred vigorously 
for 16 hours. Triphenylphospine (0.0894 g, 1 equiv, 0.3409 mmol) was added, followed 
immediately by deionized water (2.3 mL, 0.15 M), and the suspension stirred for 10 hours with a 
vent to open air. The aqueous layer was decanted, and the resulting suspension was washed 3 times 











the volatiles were removed under vacuum to afford a yellow solid. The product was recrystallized 
from THF/pentanes to afford 0.0926 g of 2-9 (0.1079 mmol, 31.6% yield).  
1H NMR (500 MHz, CDCl3): δ 7.43 – 7.32 (m, 12H), 7.24 (d, J = 7.3 Hz, 3H), 5.23 (dd, J = 10.5, 
3.3 Hz, 3H), 4.55 (s, 3H), 3.46 – 3.37 (m, 6H), 2.57 (s, 9H), 0.96 (s, 27H). 
13C NMR (126 MHz, CDCl3): δ 169.69, 134.78, 129.21, 128.44, 127.39, 126.08, 87.58, 61.26, 
40.40, 37.60, 31.09, 25.97. 
HRMS (ESI+) (m/z): [M-BF4]+ predicted for C48H63N6O3, 771.4956; found, 771.4957. 
Triethyl((2-methylcyclopent-2-en-1-yl)oxy)silane (2-19) 
 
An oven-dried (120 ºC) round-bottom Schlenk flask equipped with a stir bar was charged with 
Ni(COD)2 (0.0138 g, 0.1 equiv, 0.05 mmol), ligand 2-20 (0.0357 g, 0.1 equiv, 0.05 mmol) and 
KO-t-Bu (0.0056 g, 0.01 equiv, 0.05 mmol). THF (4.0 mL, 0.5 M) was added to the reaction 
mixture. The flask was then placed in an ice bath at 0 ºC and left to stir for approximately 50 
minutes. The ice bath was removed, and the flask was charged with Et3SiH (0.0878 g, 1.1 equiv, 
0.55 mmol). The flask was then transferred to an oil bath set at 45 ºC for 5 minutes and was charged 
with the ynal (0.0481 g, 1.0 equiv, 0.5 mmol) in a solution of THF (1.0 mL, 0.5 M). The reaction 
was left to stir overnight. The material was left to cool to room temperature and quenched with 
saturated NaHCO3. The aqueous layer was extracted with 3 times with Et2O. The combined 
organic layers were washed with brine, dried with MgSO4, filtered and concentrated. The crude 
material was purified via flash chromatography using Biotage with a hexanes:ethyl acetate 
gradient and concentrated/high–vaced to afford 0.0445 g of 2-19 (0.2095 mmol, 42% yield). 
OSiEt3
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1H NMR (500 MHz, CDCl3): δ 5.47 (s, 1H), 4.63 (t, J = 6.3 Hz, 1H), 2.45 – 2.31 (m, 1H), 2.29 – 
2.20 (m, 1H), 2.20 – 2.09 (m, 1H), 1.72 (d, J = 2.2 Hz, 3H), 1.70 – 1.65 (m, 1H), 0.98 (t, J = 7.9 
Hz, 9H), 0.63 (q, J = 7.9 Hz, 6H). 
13C NMR (126 MHz, CDCl3): δ 142.12, 127.19, 79.91, 34.52, 29.91, 13.90, 6.99, 5.03. 
8.3 Chapter 4 Experimental Details 
8.3.1 Synthesis of Carbenes 
1,3-bis-(2,4,6-trimethylphenyl)imidazole-2-ylidene (IMes) 
 
IMes was prepared according to a previous literature procedure.2 All spectral data was in 
agreement with previously reported data.2 
Bis(diisopropylamino)cyclopropenylidene (i-Pr-BAC) 
 
i-Pr-BAC was prepared according to a previous literature procedure with slight modifications.3 
An oven-dried (120 ºC) Schlenk flask equipped with a stir bar was charged brought into the 
glovebox and charged with i-Pr-BAC•HBF4 (1.0g, 1 equiv, 3.0844 mmol) and potassium 
bis(trimethylsilyl)amide (0.6153 g, 1 equiv, 3.0844 mmol). The Schlenk flask was brought out of 
the glovebox and stored under nitrogen. The Schlenk flask was cooled to -78 ºC and Et2O (23 mL, 
0.13 M) was slowly added. The suspension stirred for 10 minutes and then warmed to room 
temperature. The volatiles were removed under vacuum and the Schlenk was brought back into 
the glovebox. Pentane (approximately 23 mL) was added and the suspension stirred for 10 minutes. 




ºC) overnight. The mother liquor was decanted away from the yellow crystals. The yellow crystals 
were washed with cold pentanes to afford 0.2907 g of i-Pr-BAC (1.2296 mmol, 40% yield). All 
spectral data was in agreement with previously reported data.3  
Bis(diisopropylamino)cyclopropenium tetrafluoroborate (i-Pr-BAC•HBF4) 
 
i-Pr-BAC•HBF4 was prepared in combination of previous literature procedures with slight 
modifications.3,4,5 An oven-dried (120 ºC) round-bottom flask equipped with a stir bar was charged 
with DCM (60 mL, 0.15 M) and tetrachlorocyclopropene (1.1 mL, 1 equiv, 8.9687 mmol). The 
solution was cooled to 0 ºC and diisopropylamine (6.3 mL, 5 equiv, 4.4843 mmol) was added 
dropwise. The solution was warmed to room temperature and stirred for 6 hours. NaBF4 (0.9847 
g, 1 equiv, 8.9687 mmol) was added and the solution stirred vigorously for 16 hours. 
Triphenylphospine (2.3524 g, 1 equiv, 8.9687 mmol) was added, followed immediately by 
deionized water (60 mL, 0.15 M), and the suspension stirred for 10 hours with a vent to open air. 
The aqueous layer was decanted, and the resulting suspension was washed 3 times with deionized 
water to afford a yellow solution. The yellow solution was dried over MgSO4 and the volatiles 
were removed under vacuum to afford a yellow solid. The product was recrystallized from 
THF/pentanes to afford 1.5507g of i-Pr-BAC•HBF4 (4.7830 mmol, 53% yield). All spectral data 
was in agreement with previously reported data.5  
8.3.2 Synthesis of Fumarates 
General Procedure A 
An oven-dried (120 ºC) round-bottom flask equipped with a stir bar was charged with alcohol (2.0 




chloride (1.0 equiv) was slowly added. A precipitate formed immediately. The solution was 
allowed to warm to room temperature and stirred overnight. The reaction was quenched with the 
addition of a small amount of triethylamine. The crude reaction solution was absorbed onto silica 
gel and then added on top of a small silica gel plug. The silica gel plug was rinsed with 
dichloromethane and subsequently concentrated. In most cases, the product crystallized out upon 
the addition of pentane. In other cases, the product was purified via an alternative recrystallization 
method. In cases where the product was an oil, it was purified by flash column chromatography 
using ethyl acetate/hexanes. 
General Procedure B 
An oven-dried (120 ºC) round-bottom flask equipped with a stir bar was charged with alcohol (2.0 
equiv) and THF (0.15 M). The solution was cooled to 0 ºC where fumaryl chloride (1.0 equiv) and 
triethylamine (2.4 equiv) were added dropwise. The solution was refluxed overnight. The reaction 
was cooled to room temperature and the solvent was evaporated. The product was purified by flash 
column chromatography using 100% DCM. 
Di-tert-butyl fumarate  
 
Di-tert-butyl fumarate was prepared according to a previous literature procedure.6 All spectral data 
was in agreement with previously reported data.7 









Following general procedure A: o-cresol (1.081 g, 10.0 mmol), triethylamine (1.4 mL, 10.0 mmol) 
and fumaryl chloride (0.54 mL, 5.0 mmol) produced 0.966 g of di-o-tolyl fumarate (3.3 mmol, 
65% yield). The product was washed with pentane to afford an off-white solid. 
1H NMR (700 MHz, CDCl3): δ 7.26 – 7.23 (m, 4H + chloroform-d), 7.17 (t, J = 7.4 Hz, 2H), 7.07 
(d, J = 7.9 Hz, 2H), 2.20 (s, 6H). 
13C NMR (176 MHz, CDCl3): δ 163.06, 149.03, 134.39, 131.47, 130.06, 127.23, 126.67, 121.68, 
16.33. 
HRMS (ESI+) (m/z): [M+H]+ predicted for C18H17O4, 297.1121; found, 297.1123. 
*Synthesized and characterized by Alex Nett.8 
Dimesityl fumarate  
 
Following general procedure A: 2,4,6-trimethylphenol (11.2512 g, 82.6 mmol), triethylamine 
(11.5 mL, 82.6 mmol) and fumaryl chloride (4.5 mL, 41.3 mmol) produced 1.968 g of dimesityl 
fumarate (5.6 mmol, 14% yield). The product was recrystallized by dissolving the product in hot 
EtOH and adding a small amount of H2O. The material was stored at 0 ºC and then filtered to 
afford micro-crystallized product.  
*Please note that the reaction only ran for 2 hours instead of overnight. Additionally, the crude 
fumarate was absorbed onto silica gel and then added on top of a small silica gel plug. The silica 
gel plug was rinsed with Et2O instead of DCM as described in the general procedure and then 
subsequently concentrated. 
1H NMR (700 MHz, CDCl3): δ 7.31 (s, 2H), 6.93 – 6.90 (m, 4H), 2.29 (s, 6H), 2.15 (s, 12H). 





HRMS (ESI+) (m/z): [M+H]+ predicted for C22H25O4, 353.1753; found, 353.1747. 
*Synthesized by Alex Nett and characterized by Amie Frank. 
Bis(4-methoxyphenyl) fumarate  
 
Following general procedure A: 4-methoxyphenol (1.241 g, 10.0 mmol), triethylamine (1.4 mL, 
10.0 mmol) and fumaryl chloride (0.54 mL, 5.0 mmol) produced 3.071 g of bis(4-methoxyphenyl) 
fumarate (4.7 mmol, 94% yield). The product was recrystallized from DCM/pentane. 
1H NMR (700 MHz, CDCl3): δ 7.21 (s, 2H), 7.11 – 7.07 (m, 4H), 6.95 – 6.90 (m, 4H), 3.82 (s, 
6H). 
13C NMR (176 MHz, CDCl3): δ 163.70, 157.74, 143.91, 134.50, 122.17, 114.72, 55.77. 
HRMS (ESI+) (m/z): [M+H]+ predicted for C18H17O6, 329.1020; found, 329.1022. 
*Synthesized and characterized by Alex Nett.8 
Bis(2-methoxyphenyl) fumarate  
 
Following general procedure B: 2-methoxyphenol (1.14 g, 8.4 mmol), triethylamine (1.4 mL, 10.0 
mmol) and fumaryl chloride (0.4 mL, 4.2 mmol) produced 0.9374 g of bis(2-methoxyphenyl) 
fumarate (2.8 mmol, 66% yield). The product was purified via flash column chromatography 
using 100% DCM to afford a white crystalline solid. 
1H NMR (700 MHz, CDCl3): δ 7.27 (s, 2H), 7.26 – 7.24 (m, 2H + chloroform-d), 7.11 (dd, J = 
7.9, 1.6 Hz, 2H), 7.01 (dd, J = 8.2, 1.4 Hz, 2H), 6.98 (td, J = 7.7, 1.4 Hz, 2H), 3.85 (s, 6H). 












HRMS (ESI+) (m/z): [M+H]+ predicted for C18H17O6, 329.1025; found, 329.1020. 
*Synthesized by Santiago Cañellas and characterized by Amie Frank. 
Bis(4-(methoxycarbonyl)phenyl) fumarate  
 
Following general procedure A: 4-hydroxybenzoate (919 mg, 6.0 mmol), trimethylamine (0.84 
mL, 6.0 mmol), and fumaryl chloride (0.33 mL, 3.0 mmol) produced 2.374 g of bis(4-
(methoxycarbonyl)phenyl) fumarate (4.3 mmol, 71% yield). The product was recrystallized 
from DCM/pentane. 
1H NMR (700 MHz, CDCl3): δ 8.12 (d, J = 8.2 Hz, 4H), 7.27 – 7.25 (m, 6H + chloroform-d), 
3.93 (s, 6H). 
13C NMR (176 MHz, CDCl3): δ 166.28, 162.58, 153.85, 134.64, 131.49, 128.47, 121.44, 52.45. 
HRMS (ESI+) (m/z): [M+H]+ predicted for C20H17O8, 385.0918; found, 385.0928. 
*Synthesized and characterized by Alex Nett.8 
Dibenzhydryl fumarate 
 
Following general procedure A: diphenylmethanol (1.8323 g, 10.0 mmol), triethylamine (1.4 mL, 
10.0 mmol) and fumaryl chloride (0.54 mL, 5.0 mmol) produced 0.822 g of dibenzhydryl 
fumarate (1.8 mmol, 37% yield). The product was washed with pentane to afford a white solid. 
1H NMR (700 MHz, CDCl3): δ 7.37 – 7.33 (m, 16H), 7.30 (tdd, J = 5.1, 4.2, 2.9 Hz, 4H), 7.03 (s, 












13C NMR (176 MHz, CDCl3): δ 164.02, 139.62, 134.15, 128.76, 128.34, 127.28, 78.15. 
HRMS (ESI+) (m/z): [M-C17H13O4•] predicted for C13H11•, 167.0861; found, 167.0854. 
*Synthesized by Alex Nett and characterized by Amie Frank. 
8.3.3 Synthesis of Complexes 
General Procedure C 
An oven-dried (120 ºC) vial equipped with a stir bar was charged with Ni(COD)2 (1.0 equiv). A 
solution of fumarate (2.2 equiv) in THF was added dropwise directly to the vial containing 
Ni(COD)2 and the resulting bright red solution stirred for 15 minutes. A solution of IMes (1.0 
equiv) in THF was added and the reaction mixture stirred overnight. Volatiles were removed en 
vacuo. The desired product was either extracted with pentane and isolated by crystallization at -20 
ºC or precipitated out with the addition of pentane followed by isolation via filtration. 
General Procedure D 
An oven-dried (120 ºC) vial equipped with a stir bar was charged with Ni(COD)2 (1.0 equiv). A 
solution of IMes (1.0 equiv) in THF was added dropwise directly to the vial containing Ni(COD)2 
and the resulting dark blue-purple solution stirred for 10 minutes. A solution of fumarate (2.0 
equiv) in THF was added dropwise and the reaction mixture stirred for approximately 2.5 hours. 
Volatiles were removed en vacuo. The desired product was stirred in a solution of THF/pentane 
and then isolated via filtration. 
General Procedure E 
An oven-dried (120 ºC) vial equipped with a stir bar was charged with Ni(COD)2 (1.0 equiv) and 
IMes/i-Pr-BAC (1.0 equiv). THF was added and the resulting solution stirred for approximately 
10 minutes. A solution of fumarate (2.0 equiv) in THF was added and the red reaction mixture 
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stirred overnight. Volatiles were removed en vacuo. The desired product was crystallized and then 
collected by decantation, washed with pentanes and then dried.  
Ni(IMes)(di-tert-butyl fumarate)2 (4-6) 
 
Ni(IMes)(di-tert-butyl fumarate)2 was prepared according to a previous literature procedure.6 All 
spectral data was in agreement with previously reported data.7 
Ni(IMes)(di-o-tolyl fumarate)2 (4-12) 
 
Following general procedure C: Ni(COD)2 (200 mg, 0.73 mmol), IMes (222 mg, 0.73 mmol), and 
di-o-tolyl fumarate (432 mg, 1.46 mmol) provided a crude reaction mixture. Product was 
precipitated out as a dark red crystalline solid from the crude reaction mixture with the addition of 
pentane. Product was isolated by filtration and dried. (1.45 mg, 0.51 mmol, 70% yield) 
1H NMR (500 MHz, C6D6): δ 7.33 (dd, J = 8.0, 1.4 Hz, 2H), 7.15 (d, J = 1.2 Hz, 2H + benzene-
d6), 7.04 (td, J = 7.5, 2.0 Hz, 2H), 6.94 (dtd, J = 14.7, 7.6, 1.7 Hz, 4H), 6.87 – 6.80 (m, 4H), 6.73 
(dtd, J = 27.2, 7.6, 1.6 Hz, 4H), 6.46 (d, J = 2.0 Hz, 2H), 6.40 (s, 2H), 5.24 (d, J = 11.1 Hz, 2H), 
4.45 (d, J = 11.1 Hz, 2H), 2.43 (s, 6H), 2.20 (s, 6H), 2.07 (s, 6H), 1.97 (s, 7H), 1.93 (s, 6H). 
13C NMR (126 MHz, C6D6): δ 184.39, 169.54, 167.32, 150.49, 150.38, 138.83, 136.58, 135.82, 
134.72, 131.50, 131.24, 130.68, 130.54, 130.21, 129.46, 126.78, 126.54, 125.70, 125.39, 125.16, 














Elemental Analysis for C57H56N2NiO8: predicted, C (71.63%), N (2.93%), H (5.91%); found, C 
(71.97%), N (2.83%), H (6.39%). 
*Synthesized and characterized by Alex Nett.8 
Ni(IMes)(dimesityl fumarate)2 (4-11) 
 
Following general procedure D: Ni(COD)2 (27.5 mg, 0.10 mmol), IMes (30.4 mg, 0.10 mmol), 
and dimesityl fumarate (70.5 mg, 0.20 mmol) provided a crude reaction mixture. Product was 
precipitated out as an orange-brown solid from the crude reaction mixture. Product was stirred in 
a solution of THF/pentane, isolated via filtration and then dried to provide an orange solid. (70.7 
mg, 0.07 mmol, 66% yield) 
1H NMR (700 MHz, C6D6): Too many impurities for accurate data. NMR is attached for 
reference. 
13C NMR (176 MHz, C6D6): Too many impurities for accurate data. NMR is attached for 
reference. 
Elemental Analysis for C65H72N2NiO8: predicted, C (73.10%), H (6.80%), N (2.62%); found, C 
(70.73%), N (6.98%), H (2.46%). Would need to acquire better elemental analysis data due to 
impurities. 
*Synthesized by Alex Nett and characterized by Amie Frank. 
















Following general procedure C: Ni(COD)2 (28 mg, 0.1 mmol), IMes (30 mg, 0.1 mmol) and bis(4-
methoxyphenyl) fumarate (66 mg, 0.2 mmol) provided a crude reaction mixture. Product was 
precipitated from the crude reaction mixture with the addition of pentane and collected by 
filtration. Product was recrystallized from THF/pentane at room temperature as a dark red 
crystalline solid. (71 mg, 0.07 mmol, 71% yield) 
1H NMR (500 MHz, C6D6): δ 7.10 – 7.06 (m, 4H), 7.04 – 6.99 (m, 4H), 6.93 (d, J = 2.0 Hz, 2H), 
6.71 – 6.67 (m, 4H), 6.67 – 6.63 (m, 2H), 6.53 – 6.48 (m, 4H), 6.43 (s, 2H), 5.24 (d, J = 11.0 Hz, 
2H), 4.38 (d, J = 11.1 Hz, 2H), 3.25 (s, 6H), 3.14 (s, 6H), 2.49 (s, 6H), 2.14 (s, 6H), 2.04 (s, 6H). 
13C NMR (126 MHz, C6D6): δ 170.17, 167.89, 157.35, 157.32, 145.38, 145.22, 138.82, 136.53, 
135.86, 134.68, 130.75, 129.58, 125.07, 123.66, 123.00, 114.37, 114.30, 64.59, 57.23, 55.04, 
54.90, 21.09, 19.59, 19.53. 
Elemental Analysis for C57H56N2NiO12: predicted, C (67.14%), H (5.54%), N (2.75%); found, C 
(67.33%), N (5.49%), H (3.05%). 
*Synthesized and characterized by Alex Nett.8 
Ni(IMes)(di-o-anisole fumarate)2 (4-8) 
 
Following general procedure E: Ni(COD)2 (28 mg, 0.10 mmol), IMes (30 mg, 0.10 mmol), and 
diphenyl fumarate (54 mg, 0.20 mmol) provided a crude reaction mixture. Product was precipitated 
out as a red-orange solid/oil from the crude reaction mixture. Product was precipitated from the 
crude reaction mixture with the addition of a minimal amount of THF followed by the addition of 
pentane until formation of crystals appeared. Product was isolated by decantation, washed with 









1H NMR (700 MHz, C6D6): δ 7.33 (dd, J = 7.9, 1.6 Hz, 2H), 7.04 (dd, J = 7.8, 1.6 Hz, 2H), 6.93 
(td, J = 7.8, 1.6 Hz, 2H), 6.85 (d, J = 2.1 Hz, 2H), 6.78 (td, J = 7.7, 1.4 Hz, 2H), 6.75 – 6.70 (m, 
4H), 6.53 (dd, J = 8.2, 1.4 Hz, 2H), 6.46 (td, J = 7.7, 1.4 Hz, 2H), 6.42 (s, 2H), 6.35 (dd, J = 8.1, 
1.4 Hz, 2H), 5.54 (d, J = 11.1 Hz, 2H), 4.53 (d, J = 11.1 Hz, 2H), 3.19 (s, 7H), 3.14 (s, 7H), 2.49 
(s, 6H), 2.18 (s, 6H), 1.99 (s, 6H). 
13C NMR (176 MHz, C6D6): δ 185.96, 169.19, 167.46, 152.09, 152.03, 141.25, 141.10, 138.56, 
136.67, 136.17, 134.74, 130.60, 129.56, 126.07, 125.84, 124.93, 124.85, 123.72, 120.49, 120.31, 
112.44, 112.18, 63.80, 57.42, 55.21, 55.17, 21.00, 19.81, 19.52. 
Elemental Analysis for C57H56N2NiO12: predicted, C (67.14%), H (5.54%), N (2.75%); found, C 
(67.73%), N (5.44%), H (3.07%). 
*Synthesized by Alex Nett and characterized by Amie Frank. 
Ni(IMes)(dimethylbenzoate fumarate)2 (4-7) 
 
Following general procedure C: Ni(COD)2 (28 mg, 0.1 mmol), IMes (30 mg, 0.1 mmol) and bis(4-
(methoxycarbonyl)phenyl) fumarate (77 mg, 0.2 mmol) provided a crude reaction mixture. 
Product was precipitated out as a dark red crystalline solid from the crude reaction mixture with 
the addition of pentane. Product was isolated by filtration and dried. (101 mg, 0.09 mmol, 90% 
yield) 
1H NMR (400 MHz, C6D6): d 8.05 (d, J = 8.7 Hz, 3H), 7.87 (d, J = 8.7 Hz, 3H), 7.04 (d, J = 8.7 
Hz, 3H), 6.99 (d, J = 8.7 Hz, 3H), 6.87 (d, J = 2.0 Hz, 2H), 6.50 – 6.43 (m, 2H), 6.29 (s, 2H), 5.06 
(d, J = 10.9 Hz, 2H), 4.29 (d, J = 10.9 Hz, 2H), 3.47 (s, 5H), 3.40 (s, 5H), 2.38 (s, 5H), 1.98 (s, 










13C NMR (126 MHz, C6D6): d 183.23, 168.54, 166.01, 165.55, 165.53, 154.64, 154.50, 138.80, 
135.79, 135.12, 134.22, 130.71, 130.54, 130.10, 129.19, 124.94, 122.25, 121.32, 121.11, 65.50, 
63.48, 56.51, 51.24, 51.07, 22.31, 20.64, 18.82, 18.48, 15.18. 
Elemental Analysis for C61H56N2NiO16: predicted, C (64.73%), H (4.99%), N (2.48%); found, C 
(63.80%), N (5.21%), H (2.27%). 
*Synthesized and characterized by Alex Nett.8 
Ni(i-Pr-BAC)(dimethyl fumarate)2 (4-18) 
 
Following general procedure E: Ni(COD)2 (27.5 mg, 0.10 mmol), i-Pr-BAC (23.6 mg, 0.10 mmol), 
and dimethyl fumarate (28.8 mg, 0.20 mmol) provided a crude reaction mixture. Et2O/pentane 
mixture was added to the crude reaction mixture. A brown sludge formed and was filtered away. 
The filtrate was concentrated. Product was precipitated by adding a minimal amount of Et2O 
followed by the addition of pentane until formation of crystals appear. The crystals were left to 
form at room temperature for 10 to 30 minutes followed by enhanced crystal formation by moving 
the vial of crystals into the freezer (-20 ºC) for 30 minutes to a 1 hour. Product was isolated by 
decantation, washed with cold pentanes and then dried. (19.5 mg, 0.033 mmol, 33% yield) 
*Please note that the reaction ran for 48 hours instead of overnight. 
1H NMR (700 MHz, C6D6): δ 4.56 (d, J = 10.1 Hz, 4H), 3.68 (s, 4H), 3.59 (s, 6H), 3.29 (s, 6H), 
1.08 (s, 24H). 








Elemental Analysis for C27H44N2NiO8: predicted, C (55.59%), H (7.60%), N (4.80%); found, C 
(55.17%), N (7.58%), H (5.11%). 
Ni(i-Pr-BAC)(di-o-tolyl fumarate)2 (4-19) 
 
Following general procedure E: Ni(COD)2 (27.5 mg, 0.10 mmol), i-Pr-BAC (23.6 mg, 0.10 mmol), 
and di-o-tolyl fumarate (59.3 mg, 0.20 mmol) provided a crude reaction mixture. Product was 
precipitated by adding a minimal amount of THF followed by the addition of pentane until 
formation of crystals appear. The crystals were left to form at room temperature overnight. Product 
was isolated by decantation and then dried. A second recrystallization was performed using 
THF/pentane and stored in the freezer (-20 ºC) overnight. Product was isolated by decantation and 
then dried. (61.9 mg, 0.070 mmol, 70% yield) 
1H NMR (700 MHz, C6D6): δ 7.58 (d, J = 8.0 Hz, 2H), 7.21 (d, J = 7.9 Hz, 2H), 6.94 (d, J = 8.0 
Hz, 6H), 6.90 (p, J = 7.6 Hz, 4H), 6.84 (t, J = 7.5 Hz, 2H), 5.31 (dd, J = 11.0, 2.4 Hz, 2H), 5.10 
(dd, J = 10.9, 2.4 Hz, 2H), 3.71 (s, 4H), 2.31 (d, J = 2.3 Hz, 6H), 2.11 (d, J = 2.3 Hz, 6H), 1.09 (d, 
J = 77.7 Hz, 24H). 
13C NMR (176 MHz, C6D6): δ 169.32, 168.90, 152.97, 150.98, 150.62, 149.30, 131.13, 131.03, 
130.89, 130.77, 127.10, 126.44, 125.59, 125.39, 123.32, 122.36, 61.46, 59.95, 50.12, 21.72, 16.99, 
16.82. 
Elemental Analysis for C27H44N2NiO8: predicted, C (69.00%), H (6.81%), N (3.16%); found, C 
(69.36%), N (6.72%), H (3.49%). 









Following general procedure E: Ni(COD)2 (27.5 mg, 0.10 mmol), i-Pr-BAC (23.6 mg, 0.10 mmol), 
and dibenzhydryl fumarate (59.3 mg, 0.20 mmol) provided a crude reaction mixture. Et2O/pentane 
mixture was added to the crude reaction mixture. A brown sludge formed and was filtered away. 
The filtrate was concentrated. Product was precipitated by adding a minimal amount of Et2O 
followed by the addition of pentane until formation of crystals appear. The crystals were left to 
form in the freezer (-20 ºC) overnight. Product was isolated by decantation and then dried. (93.9 
mg, 0.079 mmol, 79% yield) 
1H NMR (700 MHz, C2D3N): δ 7.52 – 7.49 (m, 4H), 7.35 (t, J = 7.6 Hz, 4H), 7.30 (dd, J = 15.0, 
7.5 Hz, 10H), 7.27 – 7.20 (m, 20H), 7.18 (p, J = 4.2 Hz, 2H), 6.87 (s, 2H), 6.48 (s, 2H), 4.21 (d, J 
= 10.9 Hz, 2H), 4.01 (d, J = 10.9 Hz, 2H), 3.73 (s, 4H), 0.99 (s, 24H). 
13C NMR (176 MHz, C2D3N): δ 170.97, 170.94, 153.10, 142.96, 142.35, 142.03, 141.85, 129.61, 
129.51, 129.47, 129.40, 129.38, 129.03, 128.66, 128.62, 128.51, 128.41, 128.20, 127.76, 127.63, 
127.20, 127.17, 77.37, 60.90, 58.88, 21.83. 
Elemental Analysis for C27H44N2NiO8: predicted, C (75.56%), H (6.43%), N (2.35%); found, C 
(74.42%), N (6.37%), H (2.37%). 











In the glovebox Ni(IMes)(di-o-tolylfumarate)2 (71.7mg, 0.075mmol) and THF (3mL) were added 
to a large vial equipped with a stir bar. In another vial the following were added: 4-
fluorobenzaldehyde (156.1µL, 0.15 mmol), 1-phenyl-1-propyne (18.8µL, 0.15mmol), 
triethylsilane (47.9 µL, 0.30 mmol), and THF (1mL). This solution was then added to the catalyst 
solution, capped, and stirred at room temperature for 12 hours, after which dichloromethane (3 
mL) was added, and all solvent was removed by rotary evaporation. The crude mixture was then 
dissolved in dichloromethane, pushed through a plug of silica, and the solvent was removed. The 
crude material was loaded on a column (1 inch diameter, 3-4 inches of silica) and pure hexanes 
was used as the eluent to collect the following compounds: aryl silyl ether (Rf= ~0.5 in pure 
hexanes), silyl-protected allylic alcohol (Rf= ~0.4 in pure hexanes), and hydrosilyated aldehyde 
(Rf= ~0.3 in pure hexanes). After the third compound eluted, the column was flushed with EtOAc 
to collect all baseline compounds. The solvent was removed and the mixture of baseline 
compounds was loaded on a second column (1/2 inch diameter, 3 inches of silica) and 1% 
EtOAc/hexanes was used as the eluent to collect the following compounds: di-o-tolyl fumarate 
(Rf= ~0.3 in 5% EtOAc/hex), cyclopentenone byproduct (EB-I-168-6, 10.7 mg, 14% yield) (Rf= 
~0.25 in 5% EtOAc/hex), and another byproduct (EB-I-200-E, possibly the minor regioisomer of 
cyclopentenone)(Rf= ~0.1 in 5% EtOAc/hex). 
1H NMR (500 MHz, CDCl3): δ 7.40 – 7.29 (m, 5H), 7.29 – 7.14 (m, 3H + chloroform-d), 7.05 
(d, J = 7.1 Hz, 2H), 7.02 – 6.96 (m, 3H), 5.50 (d, J = 4.6 Hz, 1H), 3.87 (s, 1H), 3.61 (dd, J = 4.6, 






13C NMR (126 MHz, CDCl3): δ 204.42, 170.33, 166.60, 163.38, 161.43, 149.35, 142.33, 
136.26, 136.23, 131.48, 130.72, 130.01, 129.09, 128.45, 128.32, 128.12, 128.06, 127.20, 126.53, 
121.60, 115.14, 114.97, 72.71, 58.54, 50.55, 16.80, 16.51, 6.93, 4.84. 
HRMS (ESI+) (m/z): [M+H]+ predicted for C33H38FO4Si, 545.2518; found, 545.2518. 
*Synthesized and characterized by Ellen Butler. HRMS data obtained by Amie Frank. 
8.4 Chapter 6 Experimental Details 
General Procedure F 
An oven-dried (120 ºC) vial equipped with a stir bar was charged with (bipy)NiI2 (0.1 equiv), Mn0 
(2.0 equiv) and NaI (0.5 equiv). A solution of ynal (1.0 equiv) in DMF was added dropwise directly 
to the vial containing (bipy)NiI2. Et3SiCl (1.5 equiv) and alkyl bromide (2.0 equiv) were added 
sequentially. The reaction mixture stirred overnight. The reaction mixture was diluted with Et2O 
and quenched with brine. The organic layer was pipetted away and passed through a small silica 
plug. The aqueous layer was washed with Et2O two more times and the organic layers were passed 
through the small silica plug. The organic layers were combined, and the volatiles were removed 
en vacuo. The crude material was purified via flash chromatography using Biotage with a 
hexanes:ethyl acetate gradient and concentrated/high–vaced to afford the desired product. 
Triethyl(((E)-2-((E)-2-(1-phenylpentylidene)cyclopentyl)vinyl)oxy)silane (6-4) 
 
Following general procedure F: (bipy)NiI2 (23.4 mg, 0.05 mmol), Mn0 (54.9 mg, 1.0 mmol), NaI 
(37.5 mg, 0.25 mmol), (E)-8-phenyloct-2-en-7-ynal (99.1 mg, 0.5 mmol), Et3SiH (0.1259 mL, 0.75 




reaction mixture. The reaction was quenched by adding water and Et2O. The organic layer was 
washed twice with brine, dried over MgSO4, filtered and the volatiles were removed en vacuo. The 
crude material was purified via flash chromatography using Biotage with a hexanes:ethyl acetate 
gradient and concentrated/high–vaced to afford the desired product. (7.0 mg, 0.019 mmol, 4% 
yield) 
1H NMR (500 MHz, CDCl3): δ 7.30 (t, J = 7.5 Hz, 2H), 7.19 (t, J = 7.4 Hz, 1H), 7.11 (d, J = 6.6 
Hz, 2H), 6.29 (d, J = 10.8 Hz, 1H), 5.05 (dd, J = 12.0, 7.4 Hz, 1H), 3.34 – 3.26 (m, 1H), 2.45 – 
2.36 (m, 1H), 2.36 – 2.26 (m, 1H), 2.07 (ddt, J = 24.4, 16.4, 9.0 Hz, 2H), 1.85 – 1.77 (m, 1H), 1.64 
– 1.46 (m, 3H), 1.30 – 1.17 (m, 4H), 1.00 (t, J = 7.9 Hz, 9H), 0.82 (q, J = 7.8, 7.1 Hz, 3H), 0.68 
(q, J = 7.9 Hz, 6H). 
13C NMR (126 MHz, CDCl3): δ 144.17, 140.97, 140.12, 134.46, 128.46, 128.06, 125.92, 115.12, 
40.58, 34.99, 34.46, 31.71, 30.69, 24.10, 23.00, 14.16, 6.71, 4.64. 




Following general procedure F: (bipy)NiI2 (9.4 mg, 0.02 mmol), Mn0 (22.0 mg, 0.4 mmol), NaI 
(15.0 mg, 0.1 mmol), (E)-3-(8-phenyloct-2-en-7-ynoyl)oxazolidin-2-one (56.7 mg, 0.2 mmol), 
Et3SiH (0.0504 mL, 0.3 mmol), 1-bromobutane (0.0430 mL, 0.4 mmol) and DMF (0.2 mL, 1.0 M) 
provided a crude reaction mixture. The crude material was purified via flash chromatography using 
Biotage with a hexanes:ethyl acetate gradient and concentrated/high–vaced to afford the desired 






1H NMR (500 MHz, CDCl3): Too many impurities for accurate data. NMR is attached for 
reference. 
HRMS (ESI+) (m/z): [M+Na]+ predicted for C27H41NNaO3Si, 478.2753; found, 478.2746. 
(E)-3-(2-(2-(1-phenylpentylidene)cyclopentyl)acetyl)oxazolidin-2-one (6-11) 
 
Following general procedure F: (bipy)NiI2 (9.4 mg, 0.02 mmol), Mn0 (22.0 mg, 0.4 mmol), NaI 
(15.0 mg, 0.1 mmol), (E)-3-(8-phenyloct-2-en-7-ynoyl)oxazolidin-2-one (56.7 mg, 0.2 mmol), 
Et3SiH (0.0504 mL, 0.3 mmol), 1-bromobutane (0.0430 mL, 0.4 mmol) and DMF (0.2 mL, 1.0 M) 
provided a crude reaction mixture. The reaction was left to stir for approximately 1 hour. The vial 
was placed in an ice bath at 0 ºC TBAF (2.0 mL, 10 equiv, 2 mmol) was added dropwise. The 
reaction was quenched with NaHCO3 and transferred to a sepratory funnel and 3 extractions with 
Et2O were conducted. The aqueous layer was washed twice with brine, dried over MgSO4, filtered 
and the volatiles were removed en vacuo. The crude material was purified via flash 
chromatography using Biotage with a hexanes:ethyl acetate gradient and concentrated/high–vaced 
to afford the desired product. (4.7 mg, 0.014 mmol, 7% yield) 
1H NMR (500 MHz, CDCl3): δ 7.30 (t, J = 7.4 Hz, 2H), 7.19 (t, J = 7.4 Hz, 1H), 7.12 (d, J = 7.5 
Hz, 2H), 4.43 (t, J = 8.1 Hz, 2H), 4.06 (t, J = 8.1 Hz, 2H), 3.37 (q, J = 7.4 Hz, 1H), 3.14 – 2.99 
(m, 2H), 2.37 (t, J = 7.7 Hz, 2H), 2.17 (dt, J = 14.8, 6.5 Hz, 1H), 2.05 (dt, J = 16.1, 7.6 Hz, 1H), 
1.87 (dq, J = 13.9, 7.5, 7.0 Hz, 1H), 1.65 (dt, J = 16.7, 8.0 Hz, 1H), 1.54 (h, J = 6.0, 5.4 Hz, 2H), 
1.23 (dq, J = 28.6, 7.4 Hz, 4H), 0.81 (t, J = 7.1 Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 172.76, 153.69, 143.70, 141.64, 134.32, 128.50, 128.07, 126.07, 
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8.6 NMR Spectra 







Figure 8-1: Proton spectra of 2-9 
 







































































































































































































































Figure 8-3: Proton spectra of 2-19 
 

























































































































































































































































8.6.2 Chapter 4 NMR Spectra 
Di-o-tolyl fumarate 
 
Figure 8-5: Proton spectra for di-o-tolyl fumarate 
 











































































































































































Figure 8-7: Proton spectra for dimesityl fumarate 
 














































































































































Bis(4-methoxyphenyl) fumarate  
 
Figure 8-9: Proton spectra for bis(4-methoxyphenyl) fumarate 
 


















































































































































































Figure 8-11: Proton spectra for bis(2-methoxyphenyl) fumarate 
 






























































































































































































Bis(4-(methoxycarbonyl)phenyl) fumarate  
 
Figure 8-13: Proton spectra for bis(4-(methoxycarbonyl)phenyl) fumarate 
 




























































































































































Figure 8-15: Proton spectra for dibenzhydryl fumarate 
 


























































































































































































Ni(IMes)(di-o-tolyl fumarate)2 (4-12) 
 
Figure 8-17: Proton spectra for 4-12 
 




















































































































































































































































































































































































































































Ni(IMes)(dimesityl fumarate)2 (4-11) 
 
Figure 8-19: Proton spectra for 4-11 
 
























































































Ni(IMes)(di-p-anisole fumarate)2 (4-9) 
 
Figure 8-21: Proton spectra for 4-9 
 








































































































































































































































































































































































Ni(IMes)(di-o-anisole fumarate)2 (4-8) 
 
Figure 8-23: Proton spectra for 4-8 
 




































































































































































































































































































































































































































































Ni(i-Pr-BAC)(dimethyl fumarate)2 (4-18) 
 
Figure 8-25: Proton spectra for 4-18 
 













































































































































































Ni(i-Pr-BAC)(di-o-tolyl fumarate)2 (4-19) 
 
Figure 8-27: Proton spectra for 4-19 
 




















































































































































































































































































































Ni(i-Pr-BAC)(dibenzhydryl fumarate)2 (4-20) 
 
Figure 8-29: Proton spectra for 4-20 
 
































































































































































































































































































































Figure 8-31: Proton spectra for 4-23 
 



































































































































































































































































































































































8.6.3 Chapter 6 NMR Spectra 
Triethyl(((E)-2-((E)-2-(1-phenylpentylidene)cyclopentyl)vinyl)oxy)silane (6-4) 
 
Figure 8-33: Proton spectra for 6-4 
 

















































































































































































































































































































































































































































































































Figure 8-36: Proton spectra for 6-11 
 
Figure 8-37: Carbon spectra for 6-11 
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